eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine

HOME
QUERY
- DISEASE
- GENOTYPE
NETWORK
- PHENOTYPE
- GENE
- COMMON
- DISEASE PAIR
DOWNLOAD
SUBMIT CASE
HELP&FAQ
- HELP&FAQ
- CONTACT US


	b-cell chronic lymphocytic leukemia

Disease ID	104
Disease	b-cell chronic lymphocytic leukemia
Definition	chronic leukemia characterized by morphologically mature but immunologically less mature lymphocytes; manifested by an abnormal accumulation of these cells in blood, bone marrow, and lymphatic tissue.
Synonym	[m]chronic lymphoid leukaemia [m]chronic lymphoid leukaemia (disorder) [m]chronic lymphoid leukemia b cell chronic lymphocytic leukemia b cell cll b cell leukemia b cell leukemia, chronic b cell lymphocytic leukemia b chronic lymphocytic leukemia b lymphocytic leukemia, chronic b-cell chronic lymphocytic leukaemia b-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma b-cell chronic lymphocytic leukemia (disorder) b-cell chronic lymphocytic leukemia/small lymphocytic lymphoma b-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (morphologic abnormality) b-cell chronic lymphogenous leukemia b-cell chronic lymphoid leukemia b-cell cll b-cell leukemia b-cell leukemia, chronic b-cell leukemias, chronic b-cell lymphocytic leukemia b-cell malignancy, low-grade b-cll - b-cell chronic lymphocytic leukaemia b-cll - b-cell chronic lymphocytic leukemia b-lymphocytic leukemia, chronic b-lymphocytic leukemias, chronic bcll chronic b-cell leukemia chronic b-cell leukemias chronic b-cell lymphocytic leukemia chronic b-lymphocytic leukemia chronic b-lymphocytic leukemias chronic leukemia lymphocytic chronic lymphatic leukaemia chronic lymphatic leukemia chronic lymphoblastic leukemia chronic lymphoblastic leukemias chronic lymphocytic leukaemia chronic lymphocytic leukaemia, b-cell type chronic lymphocytic leukemia chronic lymphocytic leukemia (cll) chronic lymphocytic leukemia, b-cell chronic lymphocytic leukemia, b-cell type chronic lymphocytic leukemia, morphology (morphologic abnormality) chronic lymphocytic leukemia, nos chronic lymphocytic leukemias chronic lymphogenous leukemia chronic lymphoid leukaemia chronic lymphoid leukaemia, disease chronic lymphoid leukemia chronic lymphoid leukemia, disease chronic lymphoid leukemia, disease (disorder) cll cll - chronic lymphocytic leukaemia cll - chronic lymphocytic leukemia cll chronic lymphocytic leukemia cll lymphoplasmacytoid lymphoma cll lymphoplasmacytoid lymphomas cll, b-cell clls diffuse well differ lymphocytic lymphoma diffuse well differentiated lymphocytic lymphoma diffuse well-differentiated lymphocytic lymphoma disrupted in b-cell malignancy hematopoeitic - chronic lymphocytic leukemia (cll) leukemia b cell leukemia chronic lymphocytic leukemia lymphocytic chronic leukemia, b cell, chronic leukemia, b-cell chronic lymphocytic leukemia, b-cell, chronic leukemia, chronic b-cell leukemia, chronic b-lymphocytic leukemia, chronic lymphatic leukemia, chronic lymphocytic leukemia, chronic lymphocytic (cll) leukemia, chronic lymphocytic, b-cell leukemia, lymphoblastic, chronic leukemia, lymphocytic, chronic leukemia, lymphocytic, chronic, b cell leukemia, lymphocytic, chronic, b-cell leukemia, lymphocytic, chronic, b-cell [disease/finding] leukemias, chronic b-cell leukemias, chronic b-lymphocytic leukemias, chronic lymphoblastic lymphoblastic leukemia, chronic lymphoblastic leukemias, chronic lymphocytic leukemia chronic lymphocytic leukemia chronic b lymphocytic leukemia, b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia, chronic, b cell lymphocytic leukemia, chronic, b-cell lymphocytic leukemias, chronic lymphocytic lymphoma lymphocytic lymphoma diffuse well differ lymphocytic lymphoma well differ lymphocytic lymphoma, diffuse, well differentiated lymphocytic lymphoma, diffuse, well-differentiated lymphocytic lymphoma, small lymphocytic lymphoma, well differentiated lymphocytic lymphoma, well-differentiated lymphocytic lymphomas lymphocytic lymphomas, small lymphocytic lymphomas, well-differentiated lymphoid leukemia, chronic lymphoma lymphocytic diffuse well differ lymphoma lymphocytic well differ lymphoma small lymphoma, cll lymphoplasmacytoid lymphoma, lymphocytic lymphoma, lymphocytic, diffuse, well differentiated lymphoma, lymphocytic, diffuse, well-differentiated lymphoma, lymphocytic, well differentiated lymphoma, lymphocytic, well-differentiated lymphoma, lymphoplasmacytoid, cll lymphoma, small cell lymphoma, small lymphocytic lymphoma, small lymphocytic, plasmacytoid lymphoma, small-cell lymphoma, well-differentiated lymphocytic lymphomas, cll lymphoplasmacytoid lymphomas, lymphocytic lymphomas, small lymphocytic lymphomas, small-cell lymphomas, well-differentiated lymphocytic lymphoplasmacytoid lymphoma, cll lymphoplasmacytoid lymphomas, cll small cell lymphoma small lymphocytic lymphoma small lymphocytic lymphomas small lymphoma small-cell lymphoma small-cell lymphomas well-differentiated lymphocytic lymphoma well-differentiated lymphocytic lymphomas
Orphanet	ORPHANET:67038
OMIM	OMIM:151400 OMIM:109543
DOID	DOID:1040
UMLS	C0023434
MeSH	D015451
SNOMED-CT	SNOMEDCT_US_2016_09_01:277473004;SNOMEDCT_US_2016_09_01:92814006
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:161) C0024299 \| lymphoma \| 18 C0023418 \| leukemia \| 15 C0002871 \| anemia \| 9 C0002878 \| hemolytic anemia \| 8 C0019158 \| hepatitis \| 7 C0002880 \| autoimmune hemolytic anemia \| 6 C0040034 \| thrombocytopenia \| 5 C0349631 \| richter syndrome \| 5 C0272286 \| immune thrombocytopenia \| 4 C0024291 \| hemophagocytic lymphohistiocytosis \| 4 C0079731 \| b-cell lymphoma \| 4 C0024302 \| large cell lymphoma \| 3 C0007129 \| merkel cell carcinoma \| 3 C0023448 \| lymphocytic leukemia \| 3 C0079744 \| diffuse large b-cell lymphoma \| 3 C0025202 \| melanoma \| 3 C0040028 \| essential thrombocythemia \| 3 C0019196 \| hepatitis c \| 3 C0349631 \| richter's transformation \| 3 C0270612 \| leukoencephalopathy \| 2 C0024305 \| non-hodgkin's lymphoma \| 2 C0030807 \| pemphigus \| 2 C0836924 \| thrombocythemia \| 2 C0019829 \| hodgkin lymphoma \| 2 C0001418 \| adenocarcinoma \| 2 C0024205 \| lymphadenitis \| 2 C0042384 \| vasculitis \| 2 C0023470 \| myeloid leukemia \| 2 C0007137 \| squamous cell carcinoma \| 2 C0024314 \| lymphoproliferative disorder \| 2 C0023443 \| hairy cell leukemia \| 2 C0042769 \| viral infection \| 2 C0206180 \| anaplastic large cell lymphoma \| 2 C0035078 \| renal failure \| 2 C0027697 \| nephritis \| 2 C0553723 \| cutaneous squamous cell carcinoma \| 2 C0027707 \| interstitial nephritis \| 2 C0008325 \| cholecystitis \| 2 C0023524 \| progressive multifocal leukoencephalopathy \| 2 C0020437 \| hypercalcemia \| 2 C0042769 \| virus infection \| 2 C0042769 \| viral infections \| 2 C0007114 \| skin cancer \| 2 C0023467 \| acute myeloid leukemia \| 2 C0598894 \| monocytic leukemia \| 2 C0023434 \| chronic lymphocytic leukemia \| 2 C0015230 \| rash \| 2 C0019829 \| hodgkin's lymphoma \| 2 C0032285 \| pneumonia \| 2 C1261473 \| sarcoma \| 2 C0023470 \| myelogenous leukemia \| 1 C0025202 \| malignant melanoma \| 1 C1509147 \| histiocytoma \| 1 C0041296 \| tuberculosis \| 1 C0023486 \| prolymphocytic leukemia \| 1 C0085074 \| granuloma annulare \| 1 C0019163 \| hepatitis b \| 1 C0026948 \| mycosis fungoides \| 1 C0023492 \| t-cell leukemia \| 1 C0017665 \| membranous nephropathy \| 1 C0001125 \| lactic acidosis \| 1 C0042721 \| viral hepatitis \| 1 C0279651 \| gallbladder adenocarcinoma \| 1 C0041321 \| miliary tuberculosis \| 1 C0376358 \| prostate cancer \| 1 C0014038 \| encephalitis \| 1 C0376480 \| gingival enlargement \| 1 C0023434 \| small lymphocytic lymphoma \| 1 C0079773 \| cutaneous t-cell lymphoma \| 1 C0042721 \| hepatitis viral \| 1 C0022658 \| nephropathy \| 1 C0043541 \| zygomycosis \| 1 C0002986 \| fabry disease \| 1 C0014541 \| epiglottitis \| 1 C0029132 \| optic neuropathy \| 1 C0206067 \| focal epithelial hyperplasia \| 1 C0042109 \| urticaria \| 1 C0024419 \| macroglobulinemia \| 1 C0001824 \| agranulocytosis \| 1 C0027051 \| myocardial infarction \| 1 C0178664 \| glomerulosclerosis \| 1 C0079731 \| b cell lymphoma \| 1 C1704214 \| xanthogranuloma \| 1 C0034902 \| pure red cell aplasia \| 1 C0023290 \| visceral leishmaniasis \| 1 C0024790 \| paroxysmal nocturnal hemoglobinuria \| 1 C0027022 \| myeloproliferative neoplasms \| 1 C0699893 \| non-melanoma skin cancer \| 1 C0007102 \| colon cancer \| 1 C0001815 \| myelofibrosis \| 1 C1955861 \| t-lgl leukemia \| 1 C0023465 \| acute monocytic leukemia \| 1 C0024314 \| lymphoproliferative disorders \| 1 C0030312 \| pancytopenia \| 1 C0023281 \| leishmaniasis \| 1 C0024198 \| lyme disease \| 1 C0017668 \| focal segmental glomerulosclerosis \| 1 C0022660 \| acute renal failure \| 1 C0025309 \| meningoencephalitis \| 1 C0334463 \| malignant fibrous histiocytoma \| 1 C0027051 \| myocardial infarct \| 1 C0036416 \| scleritis \| 1 C0011991 \| diarrhea \| 1 C0008049 \| varicella \| 1 C0278678 \| metastatic renal cell carcinoma \| 1 C0004030 \| aspergillosis \| 1 C0221013 \| systemic mastocytosis \| 1 C0026764 \| myeloma \| 1 C0041349 \| tubulointerstitial nephritis \| 1 C0030326 \| panniculitis \| 1 C0019048 \| hemoglobinuria \| 1 C0026986 \| myelodysplastic syndrome \| 1 C0026764 \| multiple myeloma \| 1 C0155626 \| acute myocardial infarction \| 1 C0039446 \| telangiectasia \| 1 C0085436 \| cryptococcal meningitis \| 1 C0302592 \| cervical ca \| 1 C0007847 \| cervical cancer \| 1 C0242379 \| lung cancer \| 1 C0023493 \| adult t-cell leukemia \| 1 C0004135 \| ataxia telangiectasia \| 1 C0023798 \| lipomas \| 1 C0015624 \| fanconi syndrome \| 1 C0026946 \| mycosis \| 1 C0026277 \| pleomorphic adenoma \| 1 C0014735 \| erysipelothrix \| 1 C0600139 \| prostate carcinoma \| 1 C0162871 \| abdominal aortic aneurysm \| 1 C0024623 \| gastric cancer \| 1 C0206138 \| crest syndrome \| 1 C0030354 \| papilloma \| 1 C1302547 \| chronic lymphocytic leukemia/small lymphocytic lymphoma \| 1 C0037998 \| splenic infarction \| 1 C0002871 \| anaemia \| 1 C0003486 \| aortic aneurysm \| 1 C0012813 \| diverticulitis \| 1 C0006413 \| burkitt's lymphoma \| 1 C0014130 \| endocrinopathy \| 1 C0456909 \| blindness \| 1 C0206644 \| fibrous histiocytoma \| 1 C0024198 \| borrelia burgdorferi infection \| 1 C0279682 \| bladder adenocarcinoma \| 1 C1527336 \| sjogren syndrome \| 1 C0007134 \| renal cell carcinoma \| 1 C0025289 \| meningitis \| 1 C0023473 \| chronic myelogenous leukemia \| 1 C0018202 \| granulomatous vasculitis \| 1 C0001430 \| adenoma \| 1 C0019204 \| hepatocellular carcinoma \| 1 C0023434 \| b-cell leukemia \| 1 C0024312 \| lymphopenia \| 1 C0021053 \| immune dysfunction \| 1 C0281963 \| red cell aplasia \| 1 C0002726 \| amyloidosis \| 1 C0024899 \| mastocytosis \| 1 C0023448 \| lymphoblastic leukemia \| 1 C0442874 \| neuropathy \| 1 C0349631 \| richter's syndrome \| 1 C0007114 \| skin cancers \| 1 C0155357 \| posterior scleritis \| 1 C0011603 \| dermatitis \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:56) 595 \| CCND1 \| CTD_human;ORPHANET 406937 \| MIR145 \| CTD_human 100048912 \| CDKN2B-AS1 \| CTD_human 3117 \| HLA-DQA1 \| GWASCAT 59 \| ACTA2 \| GWASCAT 4524 \| MTHFR \| CTD_human 7157 \| TP53 \| CTD_human;ORPHANET 3569 \| IL6 \| CTD_human 11262 \| SP140 \| CTD_human;GWASCAT 406935 \| MIR143 \| CTD_human 596 \| BCL2 \| CTD_human;GWASCAT 8302 \| KLRC4 \| CTD_human 3676 \| ITGA4 \| CTD_human 5934 \| RBL2 \| CTD_human 25913 \| POT1 \| GWASCAT;ORPHANET 3394 \| IRF8 \| GWASCAT 472 \| ATM \| CTD_human;ORPHANET 7037 \| TFRC \| CTD_human 817 \| CAMK2D \| GWASCAT 5743 \| PTGS2 \| CTD_human 8792 \| TNFRSF11A \| CTD_human 25797 \| QPCT \| CTD_human 10665 \| C6orf10 \| GWASCAT 3662 \| IRF4 \| CTD_human;GWASCAT 9855 \| FARP2 \| CTD_human;GWASCAT 355 \| FAS \| GWASCAT 25865 \| PRKD2 \| CTD_human;GWASCAT 7421 \| VDR \| CTD_human 406950 \| MIR16-1 \| CTD_human 8600 \| TNFSF11 \| CTD_human 841 \| CASP8 \| GWASCAT 4988 \| OPRM1 \| GWASCAT 5423 \| POLB \| CTD_human 3500 \| IGHG1 \| ORPHANET 115761 \| ARL11 \| CTD_human;ORPHANET 29125 \| C11orf21 \| CTD_human 55289 \| ACOXL \| CTD_human;GWASCAT 81037 \| CLPTM1L \| GWASCAT 64864 \| RFX7 \| GWASCAT 23451 \| SF3B1 \| CTD_human 28444 \| IGHV3-21 \| CTD_human;ORPHANET 5027 \| P2RX7 \| CTD_human 57476 \| GRAMD1B \| GWASCAT 23547 \| LILRA4 \| CTD_human 29949 \| IL19 \| CTD_human 3431 \| SP110 \| GWASCAT 578 \| BAK1 \| GWASCAT 921 \| CD5 \| CTD_human 55892 \| MYNN \| GWASCAT 51176 \| LEF1 \| CTD_human;GWASCAT 26034 \| IPCEF1 \| GWASCAT 11073 \| TOPBP1 \| CTD_human 90427 \| BMF \| CTD_human 5527 \| PPP2R5C \| CTD_human 5366 \| PMAIP1 \| CTD_human 64506 \| CPEB1 \| CTD_human
Inferring Gene	Entrez_id \| Symbol \| Resource(Total Genes:244) 3586 \| IL10 \| CIPHER 8797 \| TNFRSF10A \| CIPHER 55289 \| ACOXL \| CIPHER;CTD_human 10018 \| BCL2L11 \| CIPHER 64506 \| CPEB1 \| CIPHER;CTD_human 30827 \| CXXC1 \| CIPHER 9855 \| FARP2 \| CIPHER;CTD_human 57476 \| GRAMD1B \| CIPHER 3569 \| IL6 \| CIPHER;CTD_human 3662 \| IRF4 \| CIPHER;CTD_human 3394 \| IRF8 \| CIPHER 4152 \| MBD1 \| CIPHER 4734 \| NEDD4 \| CIPHER 25865 \| PRKD2 \| CIPHER;CTD_human 64864 \| RFX7 \| CIPHER 3431 \| SP110 \| CIPHER 11262 \| SP140 \| CIPHER;CTD_human 29888 \| STRN4 \| CIPHER 581 \| BAX \| CIPHER 3106 \| HLA-B \| CIPHER 3115 \| HLA-DPB1 \| CIPHER 3119 \| HLA-DQB1 \| CIPHER 3123 \| HLA-DRB1 \| CIPHER 5243 \| ABCB1 \| CIPHER 207 \| AKT1 \| CIPHER 238 \| ALK \| CIPHER 317 \| APAF1 \| CIPHER 348 \| APOE \| CIPHER 472 \| ATM \| CIPHER;CTD_human 545 \| ATR \| CIPHER 9212 \| AURKB \| CIPHER 578 \| BAK1 \| CIPHER 596 \| BCL2 \| CIPHER;CTD_human 604 \| BCL6 \| CIPHER 637 \| BID \| CIPHER 332 \| BIRC5 \| CIPHER 84312 \| BRMS1L \| CIPHER 701 \| BUB1B \| CIPHER 824 \| CAPN2 \| CIPHER 825 \| CAPN3 \| CIPHER 10753 \| CAPN9 \| CIPHER 22900 \| CARD8 \| CIPHER 834 \| CASP1 \| CIPHER 843 \| CASP10 \| CIPHER 835 \| CASP2 \| CIPHER 836 \| CASP3 \| CIPHER 838 \| CASP5 \| CIPHER 841 \| CASP8 \| CIPHER 842 \| CASP9 \| CIPHER 6347 \| CCL2 \| CIPHER 10850 \| CCL27 \| CIPHER 595 \| CCND1 \| CIPHER;CTD_human 902 \| CCNH \| CIPHER 1236 \| CCR7 \| CIPHER 1237 \| CCR8 \| CIPHER 940 \| CD28 \| CIPHER 952 \| CD38 \| CIPHER 995 \| CDC25C \| CIPHER 990 \| CDC6 \| CIPHER 1021 \| CDK6 \| CIPHER 1063 \| CENPF \| CIPHER 729530 \| CNOT6LP1 \| CIPHER 1375 \| CPT1B \| CIPHER 1493 \| CTLA4 \| CIPHER 6387 \| CXCL12 \| CIPHER 7852 \| CXCR4 \| CIPHER 643 \| CXCR5 \| CIPHER 1543 \| CYP1A1 \| CIPHER 1545 \| CYP1B1 \| CIPHER 1555 \| CYP2B6 \| CIPHER 1562 \| CYP2C18 \| CIPHER 1557 \| CYP2C19 \| CIPHER 1558 \| CYP2C8 \| CIPHER 1559 \| CYP2C9 \| CIPHER 1571 \| CYP2E1 \| CIPHER 1580 \| CYP4B1 \| CIPHER 64421 \| DCLRE1C \| CIPHER 27185 \| DISC1 \| CIPHER 1870 \| E2F2 \| CIPHER 1906 \| EDN1 \| CIPHER 1950 \| EGF \| CIPHER 1956 \| EGFR \| CIPHER 2026 \| ENO2 \| CIPHER 2052 \| EPHX1 \| CIPHER 2053 \| EPHX2 \| CIPHER 2068 \| ERCC2 \| CIPHER 2072 \| ERCC4 \| CIPHER 2073 \| ERCC5 \| CIPHER 2074 \| ERCC6 \| CIPHER 114799 \| ESCO1 \| CIPHER 157570 \| ESCO2 \| CIPHER 9156 \| EXO1 \| CIPHER 2146 \| EZH2 \| CIPHER 8772 \| FADD \| CIPHER 2249 \| FGF4 \| CIPHER 79147 \| FKRP \| CIPHER 51053 \| GMNN \| CIPHER 2778 \| GNAS \| CIPHER 2939 \| GSTA2 \| CIPHER 2944 \| GSTM1 \| CIPHER 2947 \| GSTM3 \| CIPHER 2950 \| GSTP1 \| CIPHER 2952 \| GSTT1 \| CIPHER 2954 \| GSTZ1 \| CIPHER 3077 \| HFE \| CIPHER 3310 \| HSPA6 \| CIPHER 3383 \| ICAM1 \| CIPHER 29851 \| ICOS \| CIPHER 3458 \| IFNG \| CIPHER 3482 \| IGF2R \| CIPHER 3592 \| IL12A \| CIPHER 3594 \| IL12RB1 \| CIPHER 3596 \| IL13 \| CIPHER 3603 \| IL16 \| CIPHER 3606 \| IL18 \| CIPHER 3552 \| IL1A \| CIPHER 3553 \| IL1B \| CIPHER 9173 \| IL1RL1 \| CIPHER 8808 \| IL1RL2 \| CIPHER 3557 \| IL1RN \| CIPHER 3562 \| IL3 \| CIPHER 3565 \| IL4 \| CIPHER 3566 \| IL4R \| CIPHER 3568 \| IL5RA \| CIPHER 3572 \| IL6ST \| CIPHER 51135 \| IRAK4 \| CIPHER 3675 \| ITGA3 \| CIPHER 3676 \| ITGA4 \| CIPHER;CTD_human 3682 \| ITGAE \| CIPHER 3691 \| ITGB4 \| CIPHER 3981 \| LIG4 \| CIPHER 4049 \| LTA \| CIPHER 4173 \| MCM4 \| CIPHER 4174 \| MCM5 \| CIPHER 9656 \| MDC1 \| CIPHER 4193 \| MDM2 \| CIPHER 4323 \| MMP14 \| CIPHER 4317 \| MMP8 \| CIPHER 4318 \| MMP9 \| CIPHER 4436 \| MSH2 \| CIPHER 4524 \| MTHFR \| CIPHER;CTD_human 4552 \| MTRR \| CIPHER 9683 \| N4BP1 \| CIPHER 9 \| NAT1 \| CIPHER 10 \| NAT2 \| CIPHER 4683 \| NBN \| CIPHER 22861 \| NLRP1 \| CIPHER 204801 \| NLRP11 \| CIPHER 126204 \| NLRP13 \| CIPHER 338323 \| NLRP14 \| CIPHER 55655 \| NLRP2 \| CIPHER 147945 \| NLRP4 \| CIPHER 126206 \| NLRP5 \| CIPHER 126205 \| NLRP8 \| CIPHER 10392 \| NOD1 \| CIPHER 64127 \| NOD2 \| CIPHER 4843 \| NOS2 \| CIPHER 1728 \| NQO1 \| CIPHER 4986 \| OPRK1 \| CIPHER 4988 \| OPRM1 \| CIPHER 5027 \| P2RX7 \| CIPHER;CTD_human 5028 \| P2RY1 \| CIPHER 142 \| PARP1 \| CIPHER 5156 \| PDGFRA \| CIPHER 5159 \| PDGFRB \| CIPHER 5371 \| PML \| CIPHER 5426 \| POLE \| CIPHER 11201 \| POLI \| CIPHER 27343 \| POLL \| CIPHER 5529 \| PPP2R5E \| CIPHER 5591 \| PRKDC \| CIPHER 5727 \| PTCH1 \| CIPHER 5810 \| RAD1 \| CIPHER 5885 \| RAD21 \| CIPHER 5887 \| RAD23B \| CIPHER 5888 \| RAD51 \| CIPHER 5896 \| RAG1 \| CIPHER 5909 \| RAP1GAP \| CIPHER 5934 \| RBL2 \| CIPHER;CTD_human 1827 \| RCAN1 \| CIPHER 11123 \| RCAN3 \| CIPHER 51455 \| REV1 \| CIPHER 5980 \| REV3L \| CIPHER 6176 \| RPLP1 \| CIPHER 6402 \| SELL \| CIPHER 6403 \| SELP \| CIPHER 6404 \| SELPLG \| CIPHER 9154 \| SLC28A1 \| CIPHER 9153 \| SLC28A2 \| CIPHER 64078 \| SLC28A3 \| CIPHER 4092 \| SMAD7 \| CIPHER 6648 \| SOD2 \| CIPHER 401475 \| SRRM1P1 \| CIPHER 7124 \| TNF \| CIPHER 8795 \| TNFRSF10B \| CIPHER 8792 \| TNFRSF11A \| CIPHER;CTD_human 23495 \| TNFRSF13B \| CIPHER 115650 \| TNFRSF13C \| CIPHER 7133 \| TNFRSF1B \| CIPHER 8741 \| TNFSF13 \| CIPHER 10673 \| TNFSF13B \| CIPHER 7153 \| TOP2A \| CIPHER 7157 \| TP53 \| CIPHER;CTD_human 7158 \| TP53BP1 \| CIPHER 7161 \| TP73 \| CIPHER 7187 \| TRAF3 \| CIPHER 7412 \| VCAM1 \| CIPHER 7422 \| VEGFA \| CIPHER 6375 \| XCL1 \| CIPHER 7508 \| XPC \| CIPHER 7515 \| XRCC1 \| CIPHER 7516 \| XRCC2 \| CIPHER 7518 \| XRCC4 \| CIPHER 7520 \| XRCC5 \| CIPHER 2547 \| XRCC6 \| CIPHER 100131879 \| ZYG11AP1 \| CIPHER 406935 \| MIR143 \| CTD_human 406937 \| MIR145 \| CTD_human 25797 \| QPCT \| CTD_human 406950 \| MIR16-1 \| CTD_human 5423 \| POLB \| CTD_human 115761 \| ARL11 \| CTD_human 29125 \| C11orf21 \| CTD_human 23451 \| SF3B1 \| CTD_human 28444 \| IGHV3-21 \| CTD_human 23547 \| LILRA4 \| CTD_human 29949 \| IL19 \| CTD_human 921 \| CD5 \| CTD_human 7421 \| VDR \| CTD_human 51176 \| LEF1 \| CTD_human 11073 \| TOPBP1 \| CTD_human 100270642 \| CLLS3 \| CTD_human 8101 \| CLLS2 \| CTD_human 100188791 \| CLLS1 \| CTD_human 100270644 \| CLLS5 \| CTD_human 100270643 \| CLLS4 \| CTD_human 7037 \| TFRC \| CTD_human 90427 \| BMF \| CTD_human 8302 \| KLRC4 \| CTD_human 5527 \| PPP2R5C \| CTD_human 5366 \| PMAIP1 \| CTD_human 100048912 \| CDKN2B-AS1 \| CTD_human 8600 \| TNFSF11 \| CTD_human 5743 \| PTGS2 \| CTD_human
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:340) 25 \| ABL1 \| 2.326 \| DISEASES 55289 \| ACOXL \| 2.243 \| DISEASES 55 \| ACPP \| 2.368 \| DISEASES 60 \| ACTB \| 1.286 \| DISEASES 100 \| ADA \| 2.384 \| DISEASES 11086 \| ADAM29 \| 3.52 \| DISEASES 55811 \| ADCY10 \| 2.465 \| DISEASES 50808 \| AK3 \| 1.155 \| DISEASES 8227 \| AKAP17A \| 1.508 \| DISEASES 501 \| ALDH7A1 \| 1.707 \| DISEASES 238 \| ALK \| 1.835 \| DISEASES 340120 \| ANKRD34B \| 1.643 \| DISEASES 317 \| APAF1 \| 1.669 \| DISEASES 8539 \| API5 \| 1.304 \| DISEASES 94134 \| ARHGAP12 \| 1.568 \| DISEASES 84986 \| ARHGAP19 \| 1.432 \| DISEASES 57584 \| ARHGAP21 \| 1.195 \| DISEASES 57636 \| ARHGAP23 \| 1.699 \| DISEASES 9938 \| ARHGAP25 \| 1.428 \| DISEASES 201176 \| ARHGAP27 \| 1.614 \| DISEASES 23779 \| ARHGAP8 \| 1.222 \| DISEASES 64333 \| ARHGAP9 \| 1.025 \| DISEASES 221079 \| ARL5B \| 1.619 \| DISEASES 545 \| ATR \| 4.571 \| DISEASES 567 \| B2M \| 4.7 \| DISEASES 573 \| BAG1 \| 1.225 \| DISEASES 7917 \| BAG6 \| 2.381 \| DISEASES 53335 \| BCL11A \| 3.06 \| DISEASES 64919 \| BCL11B \| 2.949 \| DISEASES 596 \| BCL2 \| 2.441 \| DISEASES 10018 \| BCL2L11 \| 3.623 \| DISEASES 90427 \| BMF \| 2.503 \| DISEASES 675 \| BRCA2 \| 1.1 \| DISEASES 254065 \| BRWD3 \| 1.24 \| DISEASES 54766 \| BTG4 \| 1.903 \| DISEASES 151888 \| BTLA \| 1.22 \| DISEASES 29125 \| C11orf21 \| 1.92 \| DISEASES 28970 \| C11orf54 \| 1.671 \| DISEASES 79680 \| C22orf29 \| 1.931 \| DISEASES 801 \| CALM1 \| 1.861 \| DISEASES 84433 \| CARD11 \| 1.808 \| DISEASES 833 \| CARS \| 3.325 \| DISEASES 841 \| CASP8 \| 2.866 \| DISEASES 842 \| CASP9 \| 2.448 \| DISEASES 152137 \| CCDC50 \| 1.081 \| DISEASES 896 \| CCND3 \| 2.49 \| DISEASES 930 \| CD19 \| 6.346 \| DISEASES 912 \| CD1D \| 1.978 \| DISEASES 914 \| CD2 \| 4.252 \| DISEASES 4345 \| CD200 \| 3.937 \| DISEASES 51744 \| CD244 \| 1.378 \| DISEASES 919 \| CD247 \| 2.402 \| DISEASES 29126 \| CD274 \| 1.726 \| DISEASES 940 \| CD28 \| 1.184 \| DISEASES 951 \| CD37 \| 4.39 \| DISEASES 917 \| CD3G \| 1.448 \| DISEASES 958 \| CD40 \| 4.88 \| DISEASES 959 \| CD40LG \| 5.408 \| DISEASES 960 \| CD44 \| 2.855 \| DISEASES 961 \| CD47 \| 1.294 \| DISEASES 962 \| CD48 \| 1.124 \| DISEASES 921 \| CD5 \| 7.1 \| DISEASES 1043 \| CD52 \| 5.706 \| DISEASES 965 \| CD58 \| 2.81 \| DISEASES 966 \| CD59 \| 2.304 \| DISEASES 923 \| CD6 \| 1.895 \| DISEASES 974 \| CD79B \| 5.017 \| DISEASES 9308 \| CD83 \| 1.436 \| DISEASES 942 \| CD86 \| 3.108 \| DISEASES 926 \| CD8B \| 1.248 \| DISEASES 978 \| CDA \| 4.622 \| DISEASES 1025 \| CDK9 \| 2.042 \| DISEASES 1029 \| CDKN2A \| 2.585 \| DISEASES 1038 \| CDR1 \| 1.989 \| DISEASES 11200 \| CHEK2 \| 1.047 \| DISEASES 574028 \| CLLU1 \| 4.598 \| DISEASES 51287 \| COA4 \| 1.099 \| DISEASES 22837 \| COBLL1 \| 1.819 \| DISEASES 1378 \| CR1 \| 1.95 \| DISEASES 1380 \| CR2 \| 4.133 \| DISEASES 1435 \| CSF1 \| 1.343 \| DISEASES 1499 \| CTNNB1 \| 1.699 \| DISEASES 6387 \| CXCL12 \| 3.974 \| DISEASES 4283 \| CXCL9 \| 2.038 \| DISEASES 2833 \| CXCR3 \| 1.897 \| DISEASES 7852 \| CXCR4 \| 3.447 \| DISEASES 1612 \| DAPK1 \| 2.445 \| DISEASES 10521 \| DDX17 \| 2.065 \| DISEASES 1654 \| DDX3X \| 2.142 \| DISEASES 51428 \| DDX41 \| 1.563 \| DISEASES 9879 \| DDX46 \| 1.262 \| DISEASES 7913 \| DEK \| 1.651 \| DISEASES 56616 \| DIABLO \| 2.398 \| DISEASES 10301 \| DLEU1 \| 1.232 \| DISEASES 79469 \| DLEU2L \| 2.082 \| DISEASES 220107 \| DLEU7 \| 3.36 \| DISEASES 1758 \| DMP1 \| 1.387 \| DISEASES 120526 \| DNAJC24 \| 1.292 \| DISEASES 7266 \| DNAJC7 \| 1.425 \| DISEASES 1791 \| DNTT \| 2.686 \| DISEASES 5977 \| DPF2 \| 1.038 \| DISEASES 8110 \| DPF3 \| 1.345 \| DISEASES 51611 \| DPH5 \| 1.493 \| DISEASES 29952 \| DPP7 \| 1.535 \| DISEASES 29102 \| DROSHA \| 1.525 \| DISEASES 56940 \| DUSP22 \| 1.271 \| DISEASES 1847 \| DUSP5 \| 4.485 \| DISEASES 1850 \| DUSP8 \| 3.817 \| DISEASES 1879 \| EBF1 \| 1.301 \| DISEASES 1945 \| EFNA4 \| 1.826 \| DISEASES 1981 \| EIF4G1 \| 1.004 \| DISEASES 953 \| ENTPD1 \| 2.473 \| DISEASES 954 \| ENTPD2 \| 1.896 \| DISEASES 104355217 \| ERICD \| 1.905 \| DISEASES 30816 \| ERVW-1 \| 1.338 \| DISEASES 83850 \| ESYT3 \| 1.67 \| DISEASES 2124 \| EVI2B \| 1.013 \| DISEASES 199786 \| FAM129C \| 1.875 \| DISEASES 9130 \| FAM50A \| 1.542 \| DISEASES 355 \| FAS \| 3.753 \| DISEASES 356 \| FASLG \| 2.077 \| DISEASES 10517 \| FBXW10 \| 1.404 \| DISEASES 2209 \| FCGR1A \| 1.972 \| DISEASES 2213 \| FCGR2B \| 2.572 \| DISEASES 2214 \| FCGR3A \| 3.359 \| DISEASES 115350 \| FCRL1 \| 2.714 \| DISEASES 79368 \| FCRL2 \| 2.73 \| DISEASES 115352 \| FCRL3 \| 1.603 \| DISEASES 83416 \| FCRL5 \| 3.398 \| DISEASES 343413 \| FCRL6 \| 2.245 \| DISEASES 84824 \| FCRLA \| 2.978 \| DISEASES 2268 \| FGR \| 1.035 \| DISEASES 752 \| FMNL1 \| 1.945 \| DISEASES 2331 \| FMOD \| 3.598 \| DISEASES 2335 \| FN1 \| 2.131 \| DISEASES 2352 \| FOLR3 \| 1.287 \| DISEASES 27022 \| FOXD3 \| 1.003 \| DISEASES 50943 \| FOXP3 \| 1.839 \| DISEASES 2517 \| FUCA1 \| 1.084 \| DISEASES 2526 \| FUT4 \| 3.187 \| DISEASES 53827 \| FXYD5 \| 2.255 \| DISEASES 8326 \| FZD9 \| 1.464 \| DISEASES 104326057 \| GACAT1 \| 1.404 \| DISEASES 104797537 \| GACAT3 \| 1.33 \| DISEASES 1647 \| GADD45A \| 1.347 \| DISEASES 91227 \| GGTLC2 \| 1.416 \| DISEASES 57476 \| GRAMD1B \| 1.642 \| DISEASES 3014 \| H2AFX \| 2.382 \| DISEASES 3039 \| HBA1 \| 1.693 \| DISEASES 9734 \| HDAC9 \| 1.231 \| DISEASES 3006 \| HIST1H1C \| 1.606 \| DISEASES 8334 \| HIST1H2AC \| 2.309 \| DISEASES 3105 \| HLA-A \| 1.476 \| DISEASES 3135 \| HLA-G \| 2.138 \| DISEASES 3161 \| HMMR \| 3.168 \| DISEASES 3320 \| HSP90AA1 \| 1.78 \| DISEASES 3384 \| ICAM2 \| 1.702 \| DISEASES 3446 \| IFNA10 \| 2.229 \| DISEASES 3451 \| IFNA17 \| 1.62 \| DISEASES 3440 \| IFNA2 \| 3.53 \| DISEASES 3456 \| IFNB1 \| 1.681 \| DISEASES 100423062 \| IGLL5 \| 3.195 \| DISEASES 10320 \| IKZF1 \| 1.314 \| DISEASES 22806 \| IKZF3 \| 1.661 \| DISEASES 3586 \| IL10 \| 3.09 \| DISEASES 112744 \| IL17F \| 1.309 \| DISEASES 3559 \| IL2RA \| 3.697 \| DISEASES 3561 \| IL2RG \| 2.118 \| DISEASES 3563 \| IL3RA \| 2.889 \| DISEASES 3570 \| IL6R \| 2.02 \| DISEASES 3572 \| IL6ST \| 1.591 \| DISEASES 22876 \| INPP5F \| 1.934 \| DISEASES 26034 \| IPCEF1 \| 1.313 \| DISEASES 79711 \| IPO4 \| 2.779 \| DISEASES 3662 \| IRF4 \| 3.206 \| DISEASES 3676 \| ITGA4 \| 4.798 \| DISEASES 3683 \| ITGAL \| 3.306 \| DISEASES 3684 \| ITGAM \| 3.05 \| DISEASES 3702 \| ITK \| 1.134 \| DISEASES 3710 \| ITPR3 \| 1.444 \| DISEASES 3714 \| JAG2 \| 1.368 \| DISEASES 3716 \| JAK1 \| 1.659 \| DISEASES 3717 \| JAK2 \| 2.335 \| DISEASES 3718 \| JAK3 \| 2.185 \| DISEASES 3725 \| JUN \| 1.784 \| DISEASES 3767 \| KCNJ11 \| 1.685 \| DISEASES 283518 \| KCNRG \| 2.703 \| DISEASES 89857 \| KLHL6 \| 2.104 \| DISEASES 55975 \| KLHL7 \| 1.527 \| DISEASES 10219 \| KLRG1 \| 1.043 \| DISEASES 3903 \| LAIR1 \| 1.774 \| DISEASES 3916 \| LAMP1 \| 1.177 \| DISEASES 3932 \| LCK \| 2.713 \| DISEASES 100885779 \| LINC-ROR \| 1.92 \| DISEASES 4049 \| LTA \| 1.632 \| DISEASES 56413 \| LTB4R2 \| 1.449 \| DISEASES 4067 \| LYN \| 3.711 \| DISEASES 5609 \| MAP2K7 \| 2.397 \| DISEASES 5599 \| MAPK8 \| 1.733 \| DISEASES 4082 \| MARCKS \| 1.435 \| DISEASES 65108 \| MARCKSL1 \| 1.613 \| DISEASES 154141 \| MBOAT1 \| 2.201 \| DISEASES 4170 \| MCL1 \| 5.28 \| DISEASES 4193 \| MDM2 \| 3.304 \| DISEASES 4194 \| MDM4 \| 1.173 \| DISEASES 9968 \| MED12 \| 1.545 \| DISEASES 407975 \| MIR17HG \| 1.627 \| DISEASES 4288 \| MKI67 \| 1.118 \| DISEASES 4311 \| MME \| 4.228 \| DISEASES 4318 \| MMP9 \| 1.239 \| DISEASES 4332 \| MNDA \| 2.704 \| DISEASES 83876 \| MRO \| 1.994 \| DISEASES 54534 \| MRPL50 \| 2.215 \| DISEASES 4515 \| MTCP1 \| 3.349 \| DISEASES 92140 \| MTDH \| 1.072 \| DISEASES 9107 \| MTMR6 \| 1.225 \| DISEASES 2475 \| MTOR \| 1.641 \| DISEASES 4602 \| MYB \| 1.678 \| DISEASES 4603 \| MYBL1 \| 1.747 \| DISEASES 4609 \| MYC \| 4.013 \| DISEASES 4615 \| MYD88 \| 3.462 \| DISEASES 4675 \| NAP1L3 \| 1.442 \| DISEASES 9436 \| NCR2 \| 1.067 \| DISEASES 259197 \| NCR3 \| 1.769 \| DISEASES 4772 \| NFATC1 \| 1.246 \| DISEASES 4791 \| NFKB2 \| 1.857 \| DISEASES 4843 \| NOS2 \| 1.115 \| DISEASES 23467 \| NPTXR \| 1.801 \| DISEASES 8204 \| NRIP1 \| 1.715 \| DISEASES 22978 \| NT5C2 \| 1.732 \| DISEASES 221443 \| OARD1 \| 1.904 \| DISEASES 4942 \| OAT \| 2.668 \| DISEASES 55239 \| OGFOD1 \| 2.055 \| DISEASES 5027 \| P2RX7 \| 1.931 \| DISEASES 142 \| PARP1 \| 2.832 \| DISEASES 5079 \| PAX5 \| 3.352 \| DISEASES 84108 \| PCGF6 \| 1.517 \| DISEASES 5133 \| PDCD1 \| 1.719 \| DISEASES 5142 \| PDE4B \| 1.208 \| DISEASES 5150 \| PDE7A \| 2.255 \| DISEASES 9260 \| PDLIM7 \| 1.244 \| DISEASES 23089 \| PEG10 \| 1.474 \| DISEASES 5293 \| PIK3CD \| 3.019 \| DISEASES 5294 \| PIK3CG \| 1.472 \| DISEASES 11040 \| PIM2 \| 1.506 \| DISEASES 93035 \| PKHD1L1 \| 1.407 \| DISEASES 5336 \| PLCG2 \| 4.023 \| DISEASES 59339 \| PLEKHA2 \| 2.446 \| DISEASES 5366 \| PMAIP1 \| 3.909 \| DISEASES 4860 \| PNP \| 2.373 \| DISEASES 5422 \| POLA1 \| 1.044 \| DISEASES 25913 \| POT1 \| 1.474 \| DISEASES 5527 \| PPP2R5C \| 1.606 \| DISEASES 23532 \| PRAME \| 1.88 \| DISEASES 118471 \| PRAP1 \| 1.189 \| DISEASES 639 \| PRDM1 \| 2.389 \| DISEASES 5571 \| PRKAG1 \| 1.775 \| DISEASES 442865 \| PRYP3 \| 1.612 \| DISEASES 5728 \| PTEN \| 1.481 \| DISEASES 5788 \| PTPRC \| 3.936 \| DISEASES 5795 \| PTPRJ \| 2.072 \| DISEASES 10742 \| RAI2 \| 1.892 \| DISEASES 5923 \| RASGRF1 \| 1.093 \| DISEASES 1104 \| RCC1 \| 1.747 \| DISEASES 5970 \| RELA \| 2.313 \| DISEASES 387 \| RHOA \| 1.729 \| DISEASES 399 \| RHOH \| 2.989 \| DISEASES 6016 \| RIT1 \| 1.77 \| DISEASES 4919 \| ROR1 \| 3.666 \| DISEASES 6118 \| RPA2 \| 1.255 \| DISEASES 6209 \| RPS15 \| 2.257 \| DISEASES 26156 \| RSL1D1 \| 1.639 \| DISEASES 6305 \| SBF1 \| 1.598 \| DISEASES 10507 \| SEMA4D \| 1.947 \| DISEASES 83852 \| SETDB2 \| 1.996 \| DISEASES 23451 \| SF3B1 \| 1.413 \| DISEASES 152573 \| SHISA3 \| 1.783 \| DISEASES 59307 \| SIGIRR \| 1.052 \| DISEASES 6580 \| SLC22A1 \| 1.171 \| DISEASES 64078 \| SLC28A3 \| 2.292 \| DISEASES 2030 \| SLC29A1 \| 1.962 \| DISEASES 3177 \| SLC29A2 \| 2.344 \| DISEASES 347734 \| SLC35B2 \| 4.953 \| DISEASES 83650 \| SLC35G5 \| 2.14 \| DISEASES 6520 \| SLC3A2 \| 2.103 \| DISEASES 114798 \| SLITRK1 \| 2.469 \| DISEASES 23583 \| SMUG1 \| 1.014 \| DISEASES 6622 \| SNCA \| 1.292 \| DISEASES 677814 \| SNORA31 \| 2.326 \| DISEASES 100337591 \| SNORA70F \| 2.899 \| DISEASES 26821 \| SNORA74A \| 1.845 \| DISEASES 6664 \| SOX11 \| 3.397 \| DISEASES 11262 \| SP140 \| 2.926 \| DISEASES 6693 \| SPN \| 3.714 \| DISEASES 57213 \| SPRYD7 \| 3.466 \| DISEASES 6714 \| SRC \| 2.077 \| DISEASES 6427 \| SRSF2 \| 1.409 \| DISEASES 6772 \| STAT1 \| 2.596 \| DISEASES 6776 \| STAT5A \| 1.593 \| DISEASES 6850 \| SYK \| 4.935 \| DISEASES 8871 \| SYNJ2 \| 1.09 \| DISEASES 6932 \| TCF7 \| 1.446 \| DISEASES 8115 \| TCL1A \| 4.4 \| DISEASES 9623 \| TCL1B \| 2.806 \| DISEASES 27004 \| TCL6 \| 1.146 \| DISEASES 54790 \| TET2 \| 2.581 \| DISEASES 7037 \| TFRC \| 2.53 \| DISEASES 9967 \| THRAP3 \| 1.055 \| DISEASES 102659353 \| THRIL \| 1.471 \| DISEASES 7072 \| TIA1 \| 1.428 \| DISEASES 51284 \| TLR7 \| 2.395 \| DISEASES 54106 \| TLR9 \| 3.173 \| DISEASES 7124 \| TNF \| 3.64 \| DISEASES 8764 \| TNFRSF14 \| 1.32 \| DISEASES 8784 \| TNFRSF18 \| 1.12 \| DISEASES 3604 \| TNFRSF9 \| 2.188 \| DISEASES 10673 \| TNFSF13B \| 3.522 \| DISEASES 102800311 \| TP53COR1 \| 1.441 \| DISEASES 7185 \| TRAF1 \| 1.813 \| DISEASES 7187 \| TRAF3 \| 1.727 \| DISEASES 100887755 \| TRERNA1 \| 1.793 \| DISEASES 51592 \| TRIM33 \| 2.113 \| DISEASES 7295 \| TXN \| 1.164 \| DISEASES 127933 \| UHMK1 \| 1.775 \| DISEASES 80328 \| ULBP2 \| 1.364 \| DISEASES 7409 \| VAV1 \| 1.895 \| DISEASES 7422 \| VEGFA \| 2.565 \| DISEASES 27287 \| VENTX \| 1.278 \| DISEASES 57705 \| WDFY4 \| 1.077 \| DISEASES 23038 \| WDTC1 \| 2.096 \| DISEASES 6846 \| XCL2 \| 1.243 \| DISEASES 331 \| XIAP \| 3.599 \| DISEASES 7514 \| XPO1 \| 2.826 \| DISEASES 7520 \| XRCC5 \| 1.253 \| DISEASES 2547 \| XRCC6 \| 1.092 \| DISEASES 340152 \| ZC3H12D \| 1.176 \| DISEASES 84936 \| ZFYVE19 \| 1.898 \| DISEASES 9203 \| ZMYM3 \| 2.146 \| DISEASES 7757 \| ZNF208 \| 1.181 \| DISEASES 140883 \| ZNF280B \| 1.416 \| DISEASES
Locus	Symbol \| Locus(Total Locus:10) ARL11 \| 13q14.2 ATM \| 11q22.3 POT1 \| 7q31.33 P2RX7 \| 12q24.31 CCND1 \| 11q13.3 TP53 \| 17p13.1 IKZF3 \| 17q12-q21.1 RPS15 \| 19p13.3 IGHV3-21 \| 14q32.33 IGHG1 \| 14q32.33

Disease ID	104
Disease	b-cell chronic lymphocytic leukemia
Integrated Phenotype	HPO \| Name(Total Integrated Phenotypes:1) HP:0005550 \| Chronic lymphatic leukemia
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:102) HP:0002665 \| Lymphoma \| 19 HP:0001909 \| Leukemia \| 16 HP:0002664 \| Neoplasia \| 12 HP:0001903 \| Anemia \| 9 HP:0012115 \| Liver inflammation \| 7 HP:0001878 \| Haemolytic anaemia \| 7 HP:0012191 \| B-cell lymphoma \| 6 HP:0030731 \| Carcinoma \| 6 HP:0001873 \| Low platelet count \| 6 HP:0001890 \| Autoimmune hemolytic anemia \| 5 HP:0100827 \| Lymphocytosis \| 4 HP:0012324 \| Myeloid leukemia \| 4 HP:0002721 \| Immunodeficiency \| 4 HP:0012189 \| Hodgkin disease \| 4 HP:0001973 \| Autoimmune thrombocytopenia \| 4 HP:0002861 \| Melanoma \| 3 HP:0002716 \| Lymph node hyperplasia \| 3 HP:0000083 \| Renal insufficiency \| 3 HP:0005506 \| Chronic myeloid leukemia \| 3 HP:0001082 \| Cholecystitis \| 2 HP:0002633 \| Vasculitis \| 2 HP:0100242 \| Sarcoma \| 2 HP:0001919 \| Acute renal failure \| 2 HP:0011034 \| Amyloid disease \| 2 HP:0002352 \| Leukoencephalopathy \| 2 HP:0000123 \| Nephritis \| 2 HP:0004808 \| Acute myelogenous leukemia \| 2 HP:0012190 \| T cell lymphoma \| 2 HP:0010310 \| Chylothorax \| 2 HP:0002090 \| Pneumonia \| 2 HP:0002719 \| infections, recurrent \| 2 HP:0002840 \| Lymphadenitis \| 2 HP:0005523 \| Lymphoproliferative disorder \| 2 HP:0001970 \| Interstitial nephritis \| 2 HP:0005550 \| Chronic lymphatic leukemia \| 2 HP:0002860 \| Squamous cell carcinoma \| 2 HP:0003072 \| Hypercalcemia \| 2 HP:0200084 \| Giant cell hepatitis \| 2 HP:0000212 \| Gingival overgrowth \| 1 HP:0001138 \| Damaged optic nerve \| 1 HP:0001945 \| Fever \| 1 HP:0006554 \| Acute hepatic failure \| 1 HP:0011947 \| Respiratory infection \| 1 HP:0012192 \| Cutaneous T-cell lymphoma \| 1 HP:0000096 \| Glomerulosclerosis \| 1 HP:0002617 \| Aneurysmal dilatation \| 1 HP:0003128 \| Lactic acidosis \| 1 HP:0002202 \| Pleural effusion \| 1 HP:0001402 \| Hepatocellular carcinoma \| 1 HP:0000097 \| focal glomerulosclerosis \| 1 HP:0100532 \| Scleritis \| 1 HP:0001541 \| Ascites \| 1 HP:0004820 \| Acute myelomonocytic leukemia \| 1 HP:0012156 \| Hemophagocytosis \| 1 HP:0001063 \| Acrocyanosis \| 1 HP:0002910 \| Elevated transaminases \| 1 HP:0003003 \| Colon cancer \| 1 HP:0006775 \| Multiple myeloma \| 1 HP:0100533 \| Ocular inflammation \| 1 HP:0006824 \| Cranial nerve palsy \| 1 HP:0002835 \| Aspiration \| 1 HP:0200034 \| Papule \| 1 HP:0002383 \| Encephalitis \| 1 HP:0001888 \| Lymphocytopenia \| 1 HP:0004942 \| Aortic aneurysm \| 1 HP:0001009 \| Telangiectases \| 1 HP:0004313 \| Decreased immunoglobulin level \| 1 HP:0011974 \| Myelofibrosis \| 1 HP:0001941 \| acidemia \| 1 HP:0012234 \| Agranulocytosis \| 1 HP:0012410 \| Pure red cell aplasia \| 1 HP:0005435 \| Impaired T cell function \| 1 HP:0000618 \| Blindness \| 1 HP:0005584 \| Renal cell carcinoma \| 1 HP:0001744 \| Splenomegaly \| 1 HP:0002028 \| Chronic diarrhea \| 1 HP:0012126 \| Gastric cancer \| 1 HP:0012125 \| Prostate cancer \| 1 HP:0002960 \| Autoimmune condition \| 1 HP:0006562 \| Viral hepatitis \| 1 HP:0003641 \| Hemoglobin in urine \| 1 HP:0012315 \| Histiocytoma \| 1 HP:0012490 \| Inflammation of fat tissue \| 1 HP:0002113 \| Pulmonary infiltrates \| 1 HP:0004953 \| Abdominal aortic aneurysm \| 1 HP:0001025 \| Hives \| 1 HP:0004432 \| Agammaglobulinaemia \| 1 HP:0200029 \| Cutaneous vasculitis \| 1 HP:0100495 \| Mastocytosis \| 1 HP:0001297 \| Cerebral vascular events \| 1 HP:0001658 \| Myocardial infarction \| 1 HP:0002014 \| Diarrhea \| 1 HP:0001876 \| Low blood cell count \| 1 HP:0012578 \| Membranous glomerulonephritis \| 1 HP:0001907 \| Thromboembolic disease \| 1 HP:0001287 \| Meningitis \| 1 HP:0001399 \| Liver failure \| 1 HP:0000112 \| Nephropathy \| 1 HP:0012740 \| Papilloma \| 1 HP:0004845 \| Acute monoblastic leukemia \| 1 HP:0002863 \| Myelodysplastic syndrome \| 1 HP:0004818 \| Paroxysmal nocturnal hemoglobinuria \| 1

Disease ID	104
Disease	b-cell chronic lymphocytic leukemia
Manually Symptom	UMLS \| Name(Total Manually Symptoms:23) C2364133 \| infection C2240374 \| eosinophilia C1961102 \| lymphoblastic lymphoma C1844383 \| recurrent bacterial infections C1704231 \| leukemic meningitis C1516669 \| clonal evolution C1304408 \| urticarial vasculitis C0432412 \| trisomy 8 C0432408 \| trisomy 12 C0391861 \| plasma cell infiltration C0349631 \| richter syndrome C0334121 \| inflammatory pseudotumour C0271682 \| sensorimotor polyneuropathy C0038356 \| stomach neoplasms C0036220 \| kaposi's sarcoma C0034902 \| pure red cell aplasia C0027726 \| nephrotic syndrome C0023473 \| chronic myeloid leukemia C0017662 \| membranoproliferative glomerulonephritis C0008626 \| chromosomal abnormality C0007129 \| merkel cell carcinoma C0005699 \| blast crisis C0002880 \| autoimmune hemolytic anemia
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:54) C0009450 \| infection \| 12 C0002871 \| anemia \| 7 C0002878 \| hemolytic anemia \| 6 C0021311 \| infections \| 6 C1516669 \| clonal evolution \| 6 C0040034 \| thrombocytopenia \| 4 C0002880 \| autoimmune hemolytic anemia \| 4 C0349631 \| richter's transformation \| 3 C0024302 \| large cell lymphoma \| 3 C0272286 \| immune thrombocytopenia \| 3 C0035078 \| renal failure \| 3 C0432408 \| trisomy 12 \| 3 C0553723 \| cutaneous squamous cell carcinoma \| 2 C0023473 \| chronic myeloid leukemia \| 2 C0021051 \| immunodeficiency \| 2 C0002726 \| amyloidosis \| 2 C0008733 \| chylothorax \| 2 C0349631 \| richter syndrome \| 2 C0023443 \| hairy cell leukemia \| 2 C0007137 \| squamous cell carcinoma \| 2 C0041364 \| tumor lysis syndrome \| 2 C0020437 \| hypercalcemia \| 2 C0024205 \| lymphadenitis \| 2 C0850497 \| immune deficiency \| 2 C0948976 \| leukaemia cutis \| 2 C0023524 \| progressive multifocal leukoencephalopathy \| 2 C0032285 \| pneumonia \| 2 C0014541 \| epiglottitis \| 1 C0026986 \| myelodysplastic syndrome \| 1 C0242379 \| lung cancer \| 1 C0796095 \| c syndrome \| 1 C0032227 \| pleural effusion \| 1 C0025202 \| malignant melanoma \| 1 C0085436 \| cryptococcal meningitis \| 1 C0007129 \| merkel cell carcinoma \| 1 C0079740 \| high-grade lymphoma \| 1 C1332079 \| alk-positive anaplastic large cell lymphoma \| 1 C0085077 \| sweet syndrome \| 1 C0079746 \| plasmablastic lymphoma \| 1 C0349631 \| richter's syndrome \| 1 C0011991 \| diarrhea \| 1 C0699893 \| non-melanoma skin cancer \| 1 C0340961 \| acquired pure red cell aplasia \| 1 C0029132 \| optic neuropathy \| 1 C0024198 \| lyme disease \| 1 C1262091 \| lymphocytic infiltration \| 1 C0004610 \| bacteremia \| 1 C0021053 \| immune dysfunction \| 1 C1332225 \| aggressive lymphoma \| 1 C0034902 \| pure red cell aplasia \| 1 C0079731 \| b cell lymphoma \| 1 C0876991 \| hemophagocytosis \| 1 C0376358 \| prostate cancer \| 1 C0042384 \| vasculitis \| 1

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:249)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs1036935	20062064	30827	CXXC1	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.002638474	2010	NA	18	50317164	A	G
rs1036935	20062064	4152	MBD1	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.002367032	2010	NA	18	50317164	A	G
rs1042522	17981213	4193	MDM2	umls:C0023434	BeFree	Although the p53 R72P SNPs and MDM2 SNP309 did not associate with any of the parameters studied, the BAX G125A SNPs was associated with a more advanced Binet stage at diagnosis, supporting a potential role for this variant in CLL disease progression.	0.019445464	2007	TP53	17	7676154	G	T,C
rs1042522	17981213	581	BAX	umls:C0023434	BeFree	Although the p53 R72P SNPs and MDM2 SNP309 did not associate with any of the parameters studied, the BAX G125A SNPs was associated with a more advanced Binet stage at diagnosis, supporting a potential role for this variant in CLL disease progression.	0.016621425	2007	TP53	17	7676154	G	T,C
rs1044873	24292274	3394	IRF8	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.122638474	2013	IRF8	16	85922065	C	T
rs1045485	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	CASP8	2	201284866	G	C
rs1045485	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	CASP8	2	201284866	G	C
rs1045485	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	CASP8	2	201284866	G	C
rs1045485	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	CASP8	2	201284866	G	C
rs1045485	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	CASP8	2	201284866	G	C
rs1045642	25586345	5243	ABCB1	umls:C0023434	BeFree	Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients.	0.008338753	2014	ABCB1	7	87509329	A	T,G
rs1045642	20496015	5243	ABCB1	umls:C0023434	BeFree	MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.	0.008338753	2011	ABCB1	7	87509329	A	T,G
rs1045642	17085864	5243	ABCB1	umls:C0023434	BeFree	MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.	0.008338753	2006	ABCB1	7	87509329	A	T,G
rs1057035	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DICER1	14	95087805	T	C
rs1057035	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DICER1	14	95087805	T	C
rs1057035	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DICER1	14	95087805	T	C
rs10936599	24292274	55892	MYNN	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	MYNN	3	169774313	C	T
rs10958369	21659360	4986	OPRK1	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	NA	8	53497648	G	A
rs11083846	18758461	25865	PRKD2	umls:C0023434	GWASCAT	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	PRKD2	19	46704397	G	A
rs11083846	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	PRKD2	19	46704397	G	A
rs11083846	18758461	25865	PRKD2	umls:C0023434	GAD	[We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).]	0.24973957	2008	PRKD2	19	46704397	G	A
rs11083846	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	PRKD2	19	46704397	G	A
rs11083846	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	PRKD2	19	46704397	G	A
rs11083846	18758461	29888	STRN4	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.004734064	2008	PRKD2	19	46704397	G	A
rs11158493	21659360	5529	PPP2R5E	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	PPP2R5E	14	63486804	C	T
rs113488022	22230299	673	BRAF	umls:C0023434	BeFree	Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.	0.001085767	2012	BRAF	7	140753336	A	T,G,C
rs113488022	25511147	673	BRAF	umls:C0023434	BeFree	The performance of the BRAF V600E-specific VE1 antibody was compared with that of allele-specific polymerase chain reaction (PCR) in 22 formalin-fixed, paraffin-embedded (FFPE) specimens with HCL involvement, along with nine splenic marginal zone lymphomas (SMZLs), 10 follicular lymphomas (FLs), 10 mantle cell lymphomas (MCLs), and 10 chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLLs).	0.001085767	2015	BRAF	7	140753336	A	T,G,C
rs11540654	17981213	581	BAX	umls:C0023434	BeFree	Although the p53 R72P SNPs and MDM2 SNP309 did not associate with any of the parameters studied, the BAX G125A SNPs was associated with a more advanced Binet stage at diagnosis, supporting a potential role for this variant in CLL disease progression.	0.016621425	2007	TP53	17	7676040	C	T,G,A
rs11540654	17981213	4193	MDM2	umls:C0023434	BeFree	Although the p53 R72P SNPs and MDM2 SNP309 did not associate with any of the parameters studied, the BAX G125A SNPs was associated with a more advanced Binet stage at diagnosis, supporting a potential role for this variant in CLL disease progression.	0.019445464	2007	TP53	17	7676040	C	T,G,A
rs11554290	9139869	4893	NRAS	umls:C0023434	BeFree	Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.	0.000814326	1997	NRAS	1	114713908	T	G,C,A
rs11614913	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	MIR196A2	12	53991815	C	T
rs11614913	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	MIR196A2	12	53991815	C	T
rs11668878	20062064	79147	FKRP	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.002367032	2010	SLC1A5	19	46765116	G	T
rs1168987	21659360	84312	BRMS1L	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	NA	14	35928474	C	T
rs11866002	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	CNOT1	16	58553833	C	T
rs11866002	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	CNOT1	16	58553833	C	T
rs121913237	9139869	4893	NRAS	umls:C0023434	BeFree	Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.	0.000814326	1997	NRAS	1	114716126	C	T,G,A
rs121913250	9139869	4893	NRAS	umls:C0023434	BeFree	Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.	0.000814326	1997	NRAS	1	114716127	C	T,G,A
rs121913507	18448146	947	CD34	umls:C0855095	BeFree	The KIT mutation D816V was detected in sorted CD34(+) cells and unfractionated marrow cells but not in CD5(+) SLL cells, confirming the coexistence of 2 distinct neoplasms.	0.000271442	2008	KIT	4	54733155	A	T
rs13181	22739018	2068	ERCC2	umls:C0023434	BeFree	These preliminary data suggest a possible modifying role of Lys751Gln XPD polymorphism for the development of CLL, expecially in radiation-exposed persons.	0.005276948	2012	ERCC2;KLC3	19	45351661	T	A,G
rs13181	19484764	7515	XRCC1	umls:C0023434	BeFree	Moreover, the clearest differences were found for rs13181 in ERCC2 and rs25487 in XRCC1 between CLL patients with unfavorable cytogenetic aberrations and controls.	0.005276948	2009	ERCC2;KLC3	19	45351661	T	A,G
rs13397985	22700719	3431	SP110	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.124734064	2012	SP110;SP140	2	230226508	T	G
rs13397985	18758461	11262	SP140	umls:C0023434	GWASCAT	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	SP110;SP140	2	230226508	T	G
rs13397985	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	SP110;SP140	2	230226508	T	G
rs13397985	18758461	11262	SP140	umls:C0023434	GAD	[We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).]	0.248186863	2008	SP110;SP140	2	230226508	T	G
rs13397985	23770605	11262	SP140	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.248186863	2013	SP110;SP140	2	230226508	T	G
rs13397985	23770605	3431	SP110	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.124734064	2013	SP110;SP140	2	230226508	T	G
rs13397985	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	SP110;SP140	2	230226508	T	G
rs13397985	18758461	3431	SP110	umls:C0023434	GWASCAT	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	0.124734064	2008	SP110;SP140	2	230226508	T	G
rs13397985	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	SP110;SP140	2	230226508	T	G
rs13397985	24292274	11262	SP140	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.248186863	2013	SP110;SP140	2	230226508	T	G
rs13397985	24292274	3431	SP110	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.124734064	2013	SP110;SP140	2	230226508	T	G
rs13397985	22700719	11262	SP140	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.248186863	2012	SP110;SP140	2	230226508	T	G
rs13397985	18758461	3431	SP110	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.124734064	2008	SP110;SP140	2	230226508	T	G
rs13401811	23770605	55289	ACOXL	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.247372538	2013	ACOXL	2	110858527	G	A
rs1439287	24292274	400997	LOC400997	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	ACOXL;LOC400997	2	111114320	G	A
rs1439287	24292274	55289	ACOXL	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.247372538	2013	ACOXL;LOC400997	2	111114320	G	A
rs1494555	20952689	7124	TNF	umls:C0023434	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.021235936	2011	IL7R	5	35871088	G	A
rs16976734	24292274	64864	RFX7	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	RFX7	15	56090097	A	G
rs17028658	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	ANKS1B	12	98738334	T	C
rs17028658	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	ANKS1B	12	98738334	T	C
rs17028658	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	ANKS1B	12	98738334	T	C
rs17028658	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	ANKS1B	12	98738334	T	C
rs17028658	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	ANKS1B	12	98738334	T	C
rs17246404	24292274	25913	POT1	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.240542884	2013	POT1	7	124822607	C	A,T
rs17483466	22700719	55289	ACOXL	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.247372538	2012	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	55289	ACOXL	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.247372538	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	55289	ACOXL	umls:C0023434	GWASCAT	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	0.247372538	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	23770605	55289	ACOXL	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.247372538	2013	ACOXL;LOC105373556	2	111039881	A	G
rs17483466	18758461	10018	BCL2L11	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.008544182	2008	ACOXL;LOC105373556	2	111039881	A	G
rs17676986	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs17676986	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	SND1;SND1-IT1;LOC105375492	7	127996905	C	T
rs1799782	22106831	7515	XRCC1	umls:C0023434	BeFree	Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia.	0.005276948	2012	XRCC1	19	43553422	G	A
rs1800682	24292274	59	ACTA2	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	ACTA2;FAS	10	88990206	A	G
rs1800682	24292274	355	FAS	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.127891677	2013	ACTA2;FAS	10	88990206	A	G
rs1800890	19573080	3586	IL10	umls:C0023434	BeFree	We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/-3575T>A) to be associated with non-Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM.	0.01272543	2009	IL10	1	206776020	A	T
rs1800890	19573080	3586	IL10	umls:C0023434	GAD	[We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/-3575T>A) to be associated with non-Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM.]	0.01272543	2009	IL10	1	206776020	A	T
rs1949733	21659360	152992	TRMT44	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	TRMT44	4	8501632	A	G
rs2032582	20496015	5243	ABCB1	umls:C0023434	BeFree	MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.	0.008338753	2011	ABCB1	7	87531302	A	T,C
rs20541	20952689	7124	TNF	umls:C0023434	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.021235936	2011	IL13	5	132660272	A	G
rs210142	23770605	578	BAK1	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.122909916	2013	BAK1	6	33579060	T	C
rs210142	22700719	578	BAK1	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.122909916	2012	BAK1	6	33579060	T	C
rs2114358	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	PVT1;MIR1206	8	128008933	G	A
rs2114358	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	PVT1;MIR1206	8	128008933	G	A
rs2228226	25352360	2735	GLI1	umls:C0023434	BeFree	Association between polymorphism of GLI1 gene SNP rs2228226 and chronic lymphocytic leukemia in Chinese population.	0.001085767	2014	GLI1;ARHGAP9	12	57472038	G	C
rs2230641	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	CCNH	5	87399457	A	T,G
rs2230641	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	CCNH	5	87399457	A	T,G
rs2230641	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	CCNH	5	87399457	A	T,G
rs2230641	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	CCNH	5	87399457	A	T,G
rs2230641	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	CCNH	5	87399457	A	T,G
rs2231142	21918980	9429	ABCG2	umls:C0023434	BeFree	Furthermore, a decreased risk of chronic lymphocytic leukemia (CLL) was associated with the ABCG2 rs2231142 variant (p = 0.0004), which could be replicated in an independent population.	0.001085767	2012	ABCG2	4	88131171	G	T
rs2236256	24292274	4988	OPRM1	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.122367032	2013	OPRM1;IPCEF1	6	154157305	C	A
rs2236256	24292274	26034	IPCEF1	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	OPRM1;IPCEF1	6	154157305	C	A
rs2266690	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	NA	NA	NA	NA	NA
rs2266690	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	NA	NA	NA	NA	NA
rs2266690	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	NA	NA	NA	NA	NA
rs2266690	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	NA	NA	NA	NA	NA
rs2266690	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	NA	NA	NA	NA	NA
rs2305160	25227809	4862	NPAS2	umls:C0023434	BeFree	Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.	0.000271442	2015	NPAS2;LOC101927142	2	100974842	A	G
rs2306029	21121903	4038	LRP4	umls:C0023434	GAD	[A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.]	0.002638474	2011	LRP4;LRP4-AS1	11	46871557	T	A,C
rs2456449	20062064	9855	FARP2	umls:C0023434	BeFree	We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)).	0.242638474	2010	NA	8	127180736	A	G
rs25487	19484764	7515	XRCC1	umls:C0023434	BeFree	Moreover, the clearest differences were found for rs13181 in ERCC2 and rs25487 in XRCC1 between CLL patients with unfavorable cytogenetic aberrations and controls.	0.005276948	2009	XRCC1	19	43551574	T	C
rs25487	22106831	7515	XRCC1	umls:C0023434	BeFree	Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia.	0.005276948	2012	XRCC1	19	43551574	T	C
rs2779251	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	NOS2	17	27804300	G	A
rs2779251	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	NOS2	17	27804300	G	A
rs2779251	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	NOS2	17	27804300	G	A
rs2779251	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	NOS2	17	27804300	G	A
rs2779251	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	NOS2	17	27804300	G	A
rs2793086	21659360	27185	DISC1	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	DISC1;TSNAX-DISC1	1	231763958	T	G
rs305061	20062064	9855	FARP2	umls:C0023434	BeFree	We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)).	0.242638474	2010	LOC105371388	16	85942053	C	T
rs305061	20062064	3394	IRF8	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.122638474	2010	LOC105371388	16	85942053	C	T
rs3136597	19573080	8743	TNFSF10	umls:C0023434	GAD	[Polymorphisms in TNFSF10 were associated with both CLL and WM.]	0.007805801	2009	TNFSF10	3	172510754	G	T
rs3136687	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	CCR7	17	40561644	T	C
rs3136687	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	CCR7	17	40561644	T	C
rs3136687	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	CCR7	17	40561644	T	C
rs3136687	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	CCR7	17	40561644	T	C
rs3136687	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	CCR7	17	40561644	T	C
rs31490	24292274	81037	CLPTM1L	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	CLPTM1L	5	1344343	G	A,T
rs344550	22170086	714	C1QC	umls:C0023434	BeFree	Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases.	0.000271442	2012	C3	19	6682942	C	G
rs344550	22170086	347734	SLC35B2	umls:C0023434	BeFree	Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases.	0.012757768	2012	C3	19	6682942	C	G
rs3769825	23770605	841	CASP8	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.123995683	2013	CASP8	2	201246657	A	G
rs3805500	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs3805500	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA	5	31462870	G	A
rs386493716	22106831	7515	XRCC1	umls:C0023434	BeFree	Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia.	0.005276948	2012	NA	NA	NA	NA	NA
rs386545546	22106831	7515	XRCC1	umls:C0023434	BeFree	Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia.	0.005276948	2012	NA	NA	NA	NA	NA
rs386626619	19816006	3717	JAK2	umls:C0023434	BeFree	Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.	0.007348794	2009	NA	NA	NA	NA	NA
rs386626619	22884083	3717	JAK2	umls:C0023434	BeFree	JAK2 V617F positive essential thrombocythemia developing in a patient with CD5⁻ chronic lymphocytic leukemia.	0.007348794	2012	NA	NA	NA	NA	NA
rs386626619	22890406	3717	JAK2	umls:C0023434	BeFree	In 4 previously reported patients with JAK2(V617F)-positive Ph(-) MPN and B-CLL there was no definitive proof of JAK2(V617F) mutation in B-CLL cells, although this was suggested in 1 patient.	0.007348794	2012	NA	NA	NA	NA	NA
rs387907272	23178471	4615	MYD88	umls:C0023434	BeFree	Recurrent L265P mutation of myeloid differentiation primary response gene 88 (MYD88) has been identified in a proportion of diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia.	0.003257302	2013	MYD88	3	38141150	T	C
rs387907272	26230596	4615	MYD88	umls:C0023434	BeFree	Thus, pyrosequencing for the MYD88 L265P mutation demonstrates a high clinical sensitivity and specificity to distinguish LPL from MZL and CLL.	0.003257302	2015	MYD88	3	38141150	T	C
rs387907272	25819228	4615	MYD88	umls:C0023434	BeFree	MYD88 L265P was found in 49/51 (96%) LPL cases and in 1/13 (7·6%) MZL (splenic type), whereas all CLL samples remained negative.	0.003257302	2015	MYD88	3	38141150	T	C
rs387907272	24992174	4615	MYD88	umls:C0023434	BeFree	MYD88 L265P mutation has been reported in ∼90% of Waldenström's Macroglobulinemia (WM) patients and immunoglobulin M (IgM) monoclonal gammopathies of uncertain significance (MGUS), as well as in some cases of lymphoma and chronic lymphocytic leukemia.	0.003257302	2015	MYD88	3	38141150	T	C
rs391525	21131588	3394	IRF8	umls:C0023434	GWASCAT	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	0.122638474	2011	IRF8	16	85910833	A	G
rs438034	21659360	1063	CENPF	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	CENPF	1	214657274	A	G
rs4406737	23770605	355	FAS	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.127891677	2013	FAS;LOC105378417	10	88999967	A	G
rs4505265	19074885	3603	IL16	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.005005506	2008	NA	NA	NA	NA	NA
rs4505265	19074885	4843	NOS2	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.006448592	2008	NA	NA	NA	NA	NA
rs4505265	19074885	841	CASP8	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.123995683	2008	NA	NA	NA	NA	NA
rs4505265	19074885	1236	CCR7	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.009987267	2008	NA	NA	NA	NA	NA
rs4505265	19074885	902	CCNH	umls:C0023434	BeFree	After adjustment for multiple testing, we found a strong association between CLL risk and six genetic variants: CCNH (rs2266690, V270A), APAF1 (rs17028658, 3'region), IL16 (rs4505265, first intron), CASP8 (rs1045485, D302H), NOS2A (rs2779251, promoter), and CCR7 (rs3136687, intron 1).	0.002638474	2008	NA	NA	NA	NA	NA
rs497309	22170086	347734	SLC35B2	umls:C0023434	BeFree	Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases.	0.012757768	2012	C2	6	31924707	A	C
rs497309	22170086	714	C1QC	umls:C0023434	BeFree	Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases.	0.000271442	2012	C2	6	31924707	A	C
rs4987852	23770605	596	BCL2	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.297966465	2013	BCL2	18	63126688	T	C
rs4987855	23770605	596	BCL2	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.297966465	2013	BCL2	18	63126316	C	T
rs568408	20952689	7124	TNF	umls:C0023434	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.021235936	2011	IL12A;IL12A-AS1	3	159995680	G	A
rs6449182	21121903	952	CD38	umls:C0023434	GAD	[A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.]	0.070727741	2011	CD38	4	15778830	C	G
rs66554220	24362551	3135	HLA-G	umls:C0023434	BeFree	HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.	0.00953026	2015	NA	NA	NA	NA	NA
rs6785504	21659360	5028	P2RY1	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	NA	3	152954990	G	T
rs6858698	24292274	817	CAMK2D	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	CAMK2D	4	113762688	G	C
rs6877842	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	DROSHA;C5orf22	5	31532531	G	C
rs6877842	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	DROSHA;C5orf22	5	31532531	G	C
rs7121	17020971	2778	GNAS	umls:C0023434	BeFree	The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.	0.005634266	2006	GNAS	20	58903752	C	T
rs7121	18006055	2778	GNAS	umls:C0023434	BeFree	The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia.	0.005634266	2008	GNAS	20	58903752	C	T
rs7169431	20062064	4734	NEDD4	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.002367032	2010	NA	15	56048698	A	G
rs7169431	20062064	9855	FARP2	umls:C0023434	BeFree	We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)).	0.242638474	2010	NA	15	56048698	A	G
rs7176508	18758461	6176	RPLP1	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.002367032	2008	NA	15	69726651	A	G
rs7176508	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	NA	15	69726651	A	G
rs7176508	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	NA	15	69726651	A	G
rs7176508	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	NA	15	69726651	A	G
rs735665	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	GRAMD1B	11	123490689	G	A
rs735665	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	GRAMD1B	11	123490689	G	A
rs735665	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	GRAMD1B	11	123490689	G	A
rs735665	24292274	57476	GRAMD1B	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.127101096	2013	GRAMD1B	11	123490689	G	A
rs735665	23770605	57476	GRAMD1B	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.127101096	2013	GRAMD1B	11	123490689	G	A
rs735665	18758461	79827	CLMP	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.002367032	2008	GRAMD1B	11	123490689	G	A
rs735665	18758461	57476	GRAMD1B	umls:C0023434	GAD	[A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.]	0.127101096	2008	GRAMD1B	11	123490689	G	A
rs735665	22700719	57476	GRAMD1B	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.127101096	2012	GRAMD1B	11	123490689	G	A
rs735665	18758461	57476	GRAMD1B	umls:C0023434	GWASCAT	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	0.127101096	2008	GRAMD1B	11	123490689	G	A
rs757978	20062064	9855	FARP2	umls:C0023434	BeFree	We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)).	0.242638474	2010	FARP2	2	241431686	C	T,A
rs757978	20062064	9855	FARP2	umls:C0023434	GAD	[We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)).]	0.242638474	2010	FARP2	2	241431686	C	T,A
rs757978	23770605	9855	FARP2	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.242638474	2013	FARP2	2	241431686	C	T,A
rs77375493	22884083	3717	JAK2	umls:C0023434	BeFree	JAK2 V617F positive essential thrombocythemia developing in a patient with CD5⁻ chronic lymphocytic leukemia.	0.007348794	2012	JAK2;INSL6	9	5073770	G	A,T
rs77375493	19816006	3717	JAK2	umls:C0023434	BeFree	Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.	0.007348794	2009	JAK2;INSL6	9	5073770	G	A,T
rs77375493	22890406	3717	JAK2	umls:C0023434	BeFree	In 4 previously reported patients with JAK2(V617F)-positive Ph(-) MPN and B-CLL there was no definitive proof of JAK2(V617F) mutation in B-CLL cells, although this was suggested in 1 patient.	0.007348794	2012	JAK2;INSL6	9	5073770	G	A,T
rs783540	20062064	64506	CPEB1	umls:C0023434	GAD	[Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.]	0.122367032	2010	CPEB1	15	82585958	A	G
rs784567	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs784567	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TARBP2;MAP3K12	12	53500681	G	A
rs872071	23770605	3662	IRF4	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.254278137	2013	IRF4	6	411064	A	G
rs872071	18758461	3662	IRF4	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	IRF4	6	411064	A	G
rs872071	24292274	3662	IRF4	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.254278137	2013	IRF4	6	411064	A	G
rs872071	18758461	3662	IRF4	umls:C0023434	GWASCAT	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.254278137	2008	IRF4	6	411064	A	G
rs872071	18758461	11262	SP140	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.248186863	2008	IRF4	6	411064	A	G
rs872071	18758461	3662	IRF4	umls:C0023434	GAD	[We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).]	0.254278137	2008	IRF4	6	411064	A	G
rs872071	22700719	3662	IRF4	umls:C0023434	GWASCAT	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	0.254278137	2012	IRF4	6	411064	A	G
rs872071	18758461	25865	PRKD2	umls:C0023434	BeFree	We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).	0.24973957	2008	IRF4	6	411064	A	G
rs872071	19804451	3662	IRF4	umls:C0023434	BeFree	We have recently shown that the IRF4 variant rs872071 influences CLL risk.	0.254278137	2010	IRF4	6	411064	A	G
rs898518	23770605	51176	LEF1	umls:C0023434	GWASCAT	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	0.241900093	2013	LEF1	4	108095668	C	A
rs926070	24292274	10665	C6orf10	umls:C0023434	GWASCAT	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	0.12	2013	C6orf10;LOC101929163	6	32289789	G	A
rs9272535	21131588	3117	HLA-DQA1	umls:C0023434	GWASCAT	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	0.12	2011	HLA-DQA1	6	32638979	G	A
rs9611280	25793711	23019	CNOT1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	406973	MIR196A2	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	27044	SND1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	29102	DROSHA	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	100302170	MIR1206	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	6896	TARBP2P	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	23112	TNRC6B	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000271442	2015	TNRC6B	22	40156115	G	A
rs9611280	25793711	23405	DICER1	umls:C0023434	BeFree	We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206).	0.000542884	2015	TNRC6B	22	40156115	G	A
rs9808753	20952689	7124	TNF	umls:C0023434	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.021235936	2011	IFNGR2	21	33415005	A	G
rs9883654	21659360	5028	P2RY1	umls:C0023434	GAD	[Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses.]	0.002367032	2011	NA	3	153004186	C	T

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:103)
CHR	POS	SNPID	REF	ALT	ORI_SNPID	PMID	P_VALUE	P_VALUE_TEXT	OR/BETA	CI95_TEXT	GWAS_INITIAL_SAMPLE_SIZE	SUB_POPULATION	SUPER_POPULATION	GWAS_TRAIT	HPO_ID	HPO_TERM	DO_ID	DO_TERM	MESH_ID	MESH_TERM	EFO_ID	EFO_TERM	DOLITE_TERM	RISK_ALLELE	PUBLICATION_TYPE	AA	GENE_SYMBOL	TYPE	REFGENE
1	214830617	rs438034	A	G	rs438034	21659360	5.00E-06	NA	1.88	[1.44-2.46]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs438034-T	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
1	231899704	rs2793086	T	G	rs2793086	21659360	9.00E-06	NA	3.01	[1.51-6.01]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs2793086-C	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
2	37467264	rs2041840	T	C	rs2041840	24292274	9.00E-06	NA	1.2	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2041840-C	Meta-Analysis	Research Support, Non-U.S. Gov't	G
2	37596089	rs3770745	C	T	rs3770745	23770605	1.68E-08	NA	1.24	[1.15-1.33]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs3770745-T	Meta-Analysis	Research Support, N.I.H., Intramural	A
2	111616104	rs13401811	G	A	rs13401811	23770605	2.00E-18	NA	1.41	[1.30-1.52]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs13401811-G	Meta-Analysis	Research Support, N.I.H., Intramural	G
2	111797458	rs17483466	A	G	rs17483466	18758461	2.00E-10	NA	1.39	[1.25-1.53]	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs17483466-G	Research Support, Non-U.S. Gov't	A	ACOXL
2	111797458	rs17483466	A	G	rs17483466	22700719	5.00E-09	NA	1.43	[1.27-1.61]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	111797458	rs17483466	A	G	rs17483466	23770605	4.00E-17	NA	1.37	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs17483466-G	Meta-Analysis	Research Support, N.I.H., Intramural	A
2	111871897	rs1439287	G	A	rs1439287	24292274	5.00E-15	NA	1.37	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1439287-A	Meta-Analysis	Research Support, Non-U.S. Gov't	C
2	201740268	rs11688943	T	C	rs11688943	23770605	8.90E-08	NA	1.19	[1.12-1.28]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs11688943-T	Meta-Analysis	Research Support, N.I.H., Intramural	T
2	202111380	rs3769825	A	G	rs3769825	23770605	3.00E-09	NA	1.19	[1.12-1.25]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs3769825-T	Meta-Analysis	Research Support, N.I.H., Intramural	C
2	202153078	rs1035142	T	G	rs1035142	24292274	7.61E-05	NA	1.18	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1035142-T	Meta-Analysis	Research Support, Non-U.S. Gov't	G
2	231091223	rs13397985	T	G	rs13397985	18758461	6.00E-10	NA	1.41	[1.26-1.57]	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs13397985-G	Research Support, Non-U.S. Gov't	T	SP140
2	231091223	rs13397985	T	G	rs13397985	22700719	2.00E-07	NA	1.39	[1.23-1.59]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	231091223	rs13397985	T	G	rs13397985	23770605	1.00E-22	NA	1.45	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs13397985-G	Meta-Analysis	Research Support, N.I.H., Intramural	T
2	231091223	rs13397985	T	G	rs13397985	24292274	5.00E-13	NA	1.43	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs13397985-G	Meta-Analysis	Research Support, Non-U.S. Gov't	T
2	242192848	rs7578199	T	C	rs7578199	23770605	5.39E-07	NA	1.2	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7578199-T	Meta-Analysis	Research Support, N.I.H., Intramural	T
2	242371101	rs757978	C	T	rs757978	20062064	2.00E-09	NA	1.38	[1.25-1.56]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs757978-A	Research Support, Non-U.S. Gov't	G	FARP2
2	242371101	rs757978	C	T	rs757978	22700719	3.00E-06	NA	1.46	[1.25-1.72]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs757978-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	242371101	rs757978	C	T	rs757978	23770605	1.00E-07	NA	1.29	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs757978-A	Meta-Analysis	Research Support, N.I.H., Intramural	G
2	242371101	rs757978	C	T	rs757978	24292274	3.47E-04	NA	1.25	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs757978-T	Meta-Analysis	Research Support, Non-U.S. Gov't	G
3	152672779	rs6785504	G	T	rs6785504	21659360	7.00E-06	NA	2.11	[1.51-2.94]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs6785504-T	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
3	152721975	rs9883654	C	T	rs9883654	21659360	2.00E-06	NA	2.2	[1.57-3.08]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs9883654-T	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
3	169492101	rs10936599	C	T	rs10936599	24292274	2.00E-09	NA	1.26	[1.17-1.35]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs10936599-C	Meta-Analysis	Research Support, Non-U.S. Gov't	C
4	8503359	rs1949733	A	G	rs1949733	21659360	8.00E-07	NA	2.36	[1.60-3.47]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs1949733-A	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
4	109016824	rs898518	C	A	rs898518	23770605	4.00E-10	NA	1.2	[1.14-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs898518-A	Meta-Analysis	Research Support, N.I.H., Intramural	A
4	109026414	rs2003869	A	G	rs2003869	23770605	8.45E-08	NA	1.19	[1.12-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2003869-G	Meta-Analysis	Research Support, N.I.H., Intramural	G,A
4	114683844	rs6858698	G	C	rs6858698	24292274	3.00E-09	NA	1.31	[1.20-1.44]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs6858698-C	Meta-Analysis	Research Support, Non-U.S. Gov't	G
5	1279790	rs10069690	C	T	rs10069690	23770605	1.92E-07	NA	1.19	[1.12-1.28]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs10069690-T	Meta-Analysis	Research Support, N.I.H., Intramural	T
5	1344458	rs31490	G	A	rs31490	24292274	2.00E-07	NA	1.18	[1.11-1.26]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs31490-A	Meta-Analysis	Research Support, Non-U.S. Gov't	G
6	408079	rs1050976	C	T	rs1050976	23770605	5.83E-20	NA	1.33	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1050976-T	Meta-Analysis	Research Support, N.I.H., Intramural	C
6	411064	rs872071	A	G	rs872071	18758461	2.00E-20	NA	1.54	NA	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs872071-G	Research Support, Non-U.S. Gov't	A	IRF4
6	411064	rs872071	A	G	rs872071	22700719	8.00E-14	NA	1.47	[1.33-1.63]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs872071-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	411064	rs872071	A	G	rs872071	23770605	6.00E-20	NA	1.33	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs872071-G	Meta-Analysis	Research Support, N.I.H., Intramural	A
6	411064	rs872071	A	G	rs872071	24292274	3.00E-16	NA	1.39	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs872071-G	Meta-Analysis	Research Support, Non-U.S. Gov't	A
6	417727	rs9378805	A	C	rs9378805	21131588	2.00E-06	NA	1.38	[1.20-1.58]	407 Caucasian cases; 296 Caucasian controls	Caucasian(703)	ALL(703)	EUR(703)	ALL(703)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs9378805-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	417727	rs9378805	A	C	rs9378805	22700719	3.22E-11	NA	NA	NA	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	32257566	rs926070	G	A	rs926070	24292274	4.00E-08	0.66	1.27	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs926070-A	Meta-Analysis	Research Support, Non-U.S. Gov't	T
6	32578082	rs674313	C	T	rs674313	21131588	7.00E-09	NA	1.69	[1.41-2.01]	407 Caucasian cases; 296 Caucasian controls	Caucasian(703)	ALL(703)	EUR(703)	ALL(703)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs674313-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	32606756	rs9272535	G	A	rs9272535	21131588	9.00E-08	NA	1.61	[1.35-1.92]	407 Caucasian cases; 296 Caucasian controls	Caucasian(703)	ALL(703)	EUR(703)	ALL(703)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs9272535-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	32611641	rs9273012	A	G	rs9273012	23770605	3.51E-06	NA	1.17	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs9273012-G	Meta-Analysis	Research Support, N.I.H., Intramural	A
6	32626272	rs9273363	C	A	rs9273363	23770605	2.00E-10	NA	1.24	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs9273363-A	Meta-Analysis	Research Support, N.I.H., Intramural	C
6	33540209	rs210134	A	G	rs210134	24292274	3.00E-06	NA	1.31	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs210134-G	Meta-Analysis	Research Support, Non-U.S. Gov't	G
6	33546837	rs210142	T	C	rs210142	22700719	9.00E-16	NA	1.4	[1.25-1.57]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs210142-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	33546837	rs210142	T	C	rs210142	23770605	5.00E-08	NA	1.22	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs210142-C	Meta-Analysis	Research Support, N.I.H., Intramural	C
6	154478440	rs2236256	C	A	rs2236256	24292274	2.00E-10	NA	1.23	[1.15-1.30]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2236256-C	Meta-Analysis	Research Support, Non-U.S. Gov't	C
7	124462661	rs17246404	C	T	rs17246404	24292274	3.00E-08	NA	1.22	[1.14-1.31]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs17246404-C	Meta-Analysis	Research Support, Non-U.S. Gov't	C
8	54410208	rs10958369	G	A	rs10958369	21659360	2.00E-06	NA	2.33	[1.64-3.33]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	NA	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
8	103578874	rs2511714	T	G	rs2511714	23770605	5.00E-08	NA	1.19	[1.12-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2511714-G	Meta-Analysis	Research Support, N.I.H., Intramural	G
8	128188019	rs2466024	G	A	rs2466024	24292274	3.00E-06	NA	1.21	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2466024-A	Meta-Analysis	Research Support, Non-U.S. Gov't	A
8	128192981	rs2456449	A	G	rs2456449	20062064	8.00E-10	NA	1.26	[1.17-1.35]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2456449-G	Research Support, Non-U.S. Gov't	A	NA
8	128192981	rs2456449	A	G	rs2456449	22700719	6.31E-04	NA	NA	NA	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128209820	rs2466032	T	C	rs2466032	23770605	1.65E-08	NA	1.21	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2466032-C	Meta-Analysis	Research Support, N.I.H., Intramural	T
8	128211229	rs2466035	T	C	rs2466035	23770605	2.00E-08	NA	1.21	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2466035-C	Meta-Analysis	Research Support, N.I.H., Intramural	C
9	22206987	rs1679013	C	T	rs1679013	23770605	1.00E-08	NA	1.19	[1.12-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1679013-C	Meta-Analysis	Research Support, N.I.H., Intramural	C
9	22336996	rs1359742	G	C	rs1359742	23770605	6.08E-09	NA	1.2	[1.12-1.28]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1359742-G	Meta-Analysis	Research Support, N.I.H., Intramural	C
9	105735195	rs1342899	C	T	rs1342899	21659360	8.00E-07	NA	3.13	[1.85-5.26]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	NA	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
10	90749963	rs1800682	A	G	rs1800682	24292274	2.00E-08	NA	1.25	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1800682-A	Meta-Analysis	Research Support, Non-U.S. Gov't	C
10	90759613	rs2147420	A	G	rs2147420	23770605	3.10E-13	NA	1.26	[1.19-1.34]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2147420-G	Meta-Analysis	Research Support, N.I.H., Intramural	T
10	90759724	rs4406737	A	G	rs4406737	23770605	1.00E-14	NA	1.27	[1.19-1.33]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs4406737-G	Meta-Analysis	Research Support, N.I.H., Intramural	G
11	2311152	rs7944004	T	G	rs7944004	23770605	2.00E-10	NA	1.2	[1.13-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7944004-T	Meta-Analysis	Research Support, N.I.H., Intramural	T
11	2321095	rs2521269	C	A,G,T	rs2521269	23770605	7.23E-09	NA	1.2	[1.14-1.28]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2521269-C	Meta-Analysis	Research Support, N.I.H., Intramural	C
11	2322829	rs11022157	C	A	rs11022157	24292274	3.00E-06	NA	1.22	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs11022157-A	Meta-Analysis	Research Support, Non-U.S. Gov't	C
11	123361397	rs735665	G	A	rs735665	18758461	4.00E-12	NA	1.45	[1.31-1.61]	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs735665-A	Research Support, Non-U.S. Gov't	G	NA
11	123361397	rs735665	G	A	rs735665	22700719	3.00E-12	NA	1.52	[1.35-1.72]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs735665-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	123361397	rs735665	G	A	rs735665	23770605	4.00E-39	NA	1.62	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs735665-A	Meta-Analysis	Research Support, N.I.H., Intramural	G
11	123361397	rs735665	G	A	rs735665	24292274	4.00E-24	NA	1.64	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs735665-A	Meta-Analysis	Research Support, Non-U.S. Gov't	G
14	36397680	rs1168987	C	T	rs1168987	21659360	5.00E-06	NA	2.27	[0.31-0.63]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	rs1168987-A	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
14	63953522	rs11158493	C	T	rs11158493	21659360	9.00E-07	NA	2	[1.56-2.56]	356 European ancestary cases	European(356)	ALL(356)	EUR(356)	ALL(356)	Response to antineoplastic agents	HPOID:0002664	Neoplasm	DOID:1040	chronic lymphocytic leukemia	D000970	Antineoplastic Agents	NA	NA	Leukemia	NA	Randomized Controlled Trial	Research Support, Non-U.S. Gov't	Clinical Trial, Phase III
15	40403657	rs8024033	C	G	rs8024033	23770605	2.71E-10	NA	1.22	[1.15-1.30]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs8024033-C	Meta-Analysis	Research Support, N.I.H., Intramural	G
15	40414116	rs8023845	G	T	rs8023845	24292274	2.00E-06	NA	1.27	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs8023845-G	Meta-Analysis	Research Support, Non-U.S. Gov't	G
15	56340896	rs7169431	A	G	rs7169431	20062064	5.00E-07	NA	1.36	[1.21-1.53]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7169431-A	Research Support, Non-U.S. Gov't	A,G	NA
15	56340896	rs7169431	A	G	rs7169431	22700719	2.65E-05	NA	NA	NA	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	56340896	rs7169431	A	G	rs7169431	23770605	1.72E-05	NA	1.27	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7169431-A	Meta-Analysis	Research Support, N.I.H., Intramural	A,G
15	56382295	rs16976734	A	G	rs16976734	24292274	4.00E-07	NA	1.36	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs16976734-G	Meta-Analysis	Research Support, Non-U.S. Gov't	A
15	56775597	rs11636802	A	G	rs11636802	23770605	2.00E-13	NA	1.41	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs11636802-G	Meta-Analysis	Research Support, N.I.H., Intramural	A
15	70018990	rs7176508	A	G	rs7176508	18758461	5.00E-12	NA	1.37	[1.26-1.50]	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7176508-A	Research Support, Non-U.S. Gov't	G	NA
15	70018990	rs7176508	A	G	rs7176508	22700719	3.00E-11	NA	1.42	[1.28-1.58]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7176508-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	70018990	rs7176508	A	G	rs7176508	23770605	1.00E-17	NA	1.32	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7176508-A	Meta-Analysis	Research Support, N.I.H., Intramural	G
15	70018990	rs7176508	A	G	rs7176508	24292274	8.00E-18	NA	1.42	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7176508-A	Meta-Analysis	Research Support, Non-U.S. Gov't	G
15	83254708	rs783540	A	G	rs783540	20062064	4.00E-06	NA	1.18	[1.10-1.27]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs783540-G	Research Support, Non-U.S. Gov't	A	CPEB1
15	83398315	rs7163848	C	T	rs7163848	24292274	7.00E-05	NA	0.22	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs7163848-C	Meta-Analysis	Research Support, Non-U.S. Gov't	C
16	85927814	rs391023	C	T	rs391023	23770605	5.00E-17	NA	1.33	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs391023-G	Meta-Analysis	Research Support, N.I.H., Intramural	A
16	85944439	rs391525	A	G	rs391525	21131588	3.00E-09	NA	1.56	[1.35-1.82]	407 Caucasian cases; 296 Caucasian controls	Caucasian(703)	ALL(703)	EUR(703)	ALL(703)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	85944439	rs391525	A	G	rs391525	22700719	5.40E-07	NA	NA	NA	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	85944823	rs2292982	T	G	rs2292982	23770605	4.76E-17	NA	1.33	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs2292982-A	Meta-Analysis	Research Support, N.I.H., Intramural	C
16	85955671	rs1044873	C	T	rs1044873	24292274	1.00E-09	NA	1.29	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1044873-C	Meta-Analysis	Research Support, Non-U.S. Gov't	T
16	85975659	rs305061	C	T	rs305061	20062064	4.00E-07	NA	1.22	[1.12-1.32]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs305061-T	Research Support, Non-U.S. Gov't	C,T	NA
16	85975659	rs305061	C	T	rs305061	22700719	9.00E-08	NA	1.33	[1.20-1.49]	1,121 European ancestry cases; 3,745 European ancestry controls	European(4866)	ALL(4866)	EUR(4866)	ALL(4866)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	85975659	rs305061	C	T	rs305061	23770605	8.76E-06	NA	1.16	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs305061-T	Meta-Analysis	Research Support, N.I.H., Intramural	C,T
18	47837796	rs12970172	T	C	rs12970172	23770605	5.06E-04	NA	1.15	NA	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs12970172-C	Meta-Analysis	Research Support, N.I.H., Intramural	T
18	47843534	rs1036935	A	G	rs1036935	20062064	2.00E-06	NA	1.22	[1.12-1.32]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs1036935-T	Research Support, Non-U.S. Gov't	C	NA
18	57568693	rs7240884	A	G	rs7240884	24292274	1.50E-05	NA	1.19	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Meta-Analysis	Research Support, Non-U.S. Gov't	G
18	57622287	rs4368253	T	C	rs4368253	23770605	3.00E-08	NA	1.19	[1.12-1.27]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs4368253-C	Meta-Analysis	Research Support, N.I.H., Intramural	C
18	58037433	rs35748167	G	C	rs35748167	23770605	9.31E-09	NA	1.32	[1.19-1.43]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs35748167-G	Meta-Analysis	Research Support, N.I.H., Intramural	C
18	60793494	rs4987856	C	T	rs4987856	23770605	5.71E-11	NA	1.45	[1.30-1.61]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs4987856-C	Meta-Analysis	Research Support, N.I.H., Intramural	G
18	60793549	rs4987855	C	T	rs4987855	23770605	3.00E-12	NA	1.47	[1.32-1.61]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs4987855-G	Meta-Analysis	Research Support, N.I.H., Intramural	G
18	60793921	rs4987852	T	C	rs4987852	23770605	8.00E-11	NA	1.41	[1.27-1.56]	2,179 European ancestry cases; 6,221 European ancestry controls	European(8400)	ALL(8400)	EUR(8400)	ALL(8400)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	NA	Meta-Analysis	Research Support, N.I.H., Intramural	A
18	60793921	rs4987852	T	C	rs4987852	24292274	8.00E-05	NA	1.35	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs4987852-C	Meta-Analysis	Research Support, Non-U.S. Gov't	A
19	47207654	rs11083846	G	A	rs11083846	18758461	4.00E-09		1.35	[1.22-1.49]	505 cases; 1,438 controls	NOPOP(1943)	ALL(1943)	NOPOP(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs11083846-A	Research Support, Non-U.S. Gov't	G	PRKD2
19	47268373	rs11668878	G	T	rs11668878	20062064	4.00E-07	NA	1.37	[1.21-1.55]	505 European cases; 1,438 European controls	European(1943)	ALL(1943)	EUR(1943)	ALL(1943)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs11668878-T	Research Support, Non-U.S. Gov't	G	NA
19	47287507	rs3027957	T	C	rs3027957	24292274	1.25E-05	NA	1.25	NA	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs3027957-C	Meta-Analysis	Research Support, Non-U.S. Gov't	A
20	62341931	rs6062501	T	G	rs6062501	24292274	1.47E-05	NA	1.19	[1.10-1.29]	1,739 European ancestry cases; 5,199 European ancestry controls	European(6938)	ALL(6938)	EUR(6938)	ALL(6938)	Chronic lymphocytic leukemia	HPOID:0005550	Chronic lymphatic leukemia	DOID:1040	chronic lymphocytic leukemia	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	EFOID:0000095	chronic lymphocytic leukemia	Leukemia	rs6062501-T	Meta-Analysis	Research Support, Non-U.S. Gov't	T

Mapped by lexical matching(Total Items:1)
HP ID	HP Name	MP ID	MP Name	Annotation
HP:0005550	Chronic lymphatic leukemia	MP:0002026	increased leukemia incidence	higher than normal incidence of a cancer characterized by progressive proliferation of abnormal leukocytes in hematopoietic tissues, organs and blood

Mapped by homologous gene(Total Items:1)
HP ID	HP Name	MP ID	MP Name	Annotation
HP:0005550	Chronic lymphatic leukemia	MP:0014127	increased thymoma incidence	greater than the expected number of a malignant neoplasm originating from the epithelial cells of the thymus, occurring in a specific population in a given time period; thymoma is an uncommon tumor linked with myasthenia gravis and other autoimmune diseas

Disease ID	104
Disease	b-cell chronic lymphocytic leukemia
Case	(Waiting for update.)